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Abstract 
Background: While cognitive impairment is a core feature of schizophrenia, a minority of 
patients demonstrate average to superior ability on many standard cognitive measures with no 
attenuation of the psychotic disease process (Heinrichs et al. 2008; Muharib et al., 2014). The 
data imply a dissociation of cognitive and psychosis-generating neural mechanisms whereby 
patients share a disease process that leads to psychosis but vary in terms of the pathophysiology 
that causes cognitive impairment. Furthermore, current views hold that schizophrenia involves 
abnormalities in the connectivity of large-scale brain networks [default mode (DMN), salience 
(SN), central executive (CEN), and social brain (SBN)]. However, these findings may reflect 
pathophysiology related to both the cognitive and psychotic features of schizophrenia. Therefore, 
we asked: Are aberrations in cortical thickness and/or structural connectivity within and between 
networks associated with cognitive impairment and/or the severity of psychotic 
psychopathology? Method: Structural magnetic resonance (MRI) and diffusion tensor imaging 
(DTI), cognitive, and clinical data were collected from 121 participants, which include 16 
cognitively-intact and 48 cognitively-impaired schizophrenia patients as well as 36 cognitively 
normal and 21 below-normal controls. Between-group comparisons and region-of-interest 
analyses of cortical thickness and structural integrity in the DMN, SN, CEN, and SBN were 
performed on MRI and DTI data. Results: Cognitively normal controls had greater DMN and 
SN cortical thickness than both cognitively normal and below-normal patients. Structural 
integrity of the genu of the corpus callosum was significantly different between cognitively 
normal controls and both patient groups. Superior longitudinal fasciculus connectivity patterns 
differed between cognitively normal controls and below-normal patients. Lastly, the inferior 
longitudinal and inferior fronto-occipital fasciculi combined were significantly different between 
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cognitively normal controls and patients. Conclusions: The results suggest that cortical thinning 
may represent the presence of psychotic psychopathology independent of cognitive impairment. 
However, tract integrity may index cognitive status, the psychotic disease process, or both. The 
similarities in white matter integrity associations with cognition among cognitively normal 
patients and controls suggest shared neurocognitive processes, and the dissimilarities may point 
to cortical structure aberrations that give rise to psychotic psychopathology. Taken together, this 
study contributes to the advancement of the literature by providing evidence for dissociable or 
partially dissociable disease processes in psychotic illness. 
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1 
Abnormal Structural Connectivity Patterns in Large-Scale Brain Networks in 
Schizophrenia 
Introduction 
Schizophrenia is a chronic debilitating disorder characterized by positive and negative 
symptoms as well as disruptions in social and occupational functioning. Positive symptoms refer 
to psychotic behaviour that is not typically found in the general population. Negative symptoms, 
on the other hand, represent the absence of or disruption in normal functioning. Disease onset 
typically begins in late adolescence to early adulthood. Symptoms may include implausible 
beliefs (delusions), distorted sensory perceptions (hallucinations), thought disorder (disorganized 
speech), abnormal psychomotor behaviour, loss of interest and motivation, social withdrawal, 
apathy, and impoverished emotional expression. Cognitive impairment is a correlate of the 
disorder, and frequently found in patients. The heterogeneity in clinical presentation is reflected 
in the interindividual variability of symptom expression, presence and/or severity of cognitive 
impairment, illness onset and course, clinical and functional outcome/recovery pattern, and 
treatment-response; heterogeneity is also observed in neurobiological findings (including genetic 
and cortical structural differences) (Brugger & Howes, 2017). The heterogeneous clinical 
presentations have contributed to the conceptualization of schizophrenia as a clinical syndrome 
with various symptoms, rather than a single disease (Insel, 2010).  
The chronicity and disabling course of the illness are highlighted in the relapses of 
psychotic symptoms that are more the norm than the exception and linked to functional 
deterioration and poorer prognosis (Kessler & Lev-Ran, 2019). Only approximately 14% achieve 
clinical remission (i.e., loss of symptoms combined with return to premorbid functioning) and 
social recovery (i.e., minimal social dysfunction with independent economic and residential 
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functioning) with a 2-year maintenance of improvements in one or both domains (see 
Jääskeläinen et al., 2013 for a review). The additional presence of common comorbid conditions 
of substance use, depression, and anxiety further contribute to the complexity of the disorder 
(Tsai & Rosenheck, 2013; Kessler & Lev-Ran, 2019).  
Given the chronicity and complexity of the disease that significantly impacts functioning, 
this disorder is considered one of the most disabling illnesses worldwide (World Health 
Organization, 2008). It is known as the “cancer of mental illness” due to its significant morbidity 
and mortality rates, through its elevation of suicide risk and poor physical health, causing both 
domestic and international economic burden (Birnbaum & Weinberger, 2017). Individuals with 
the disorder tend to be repeat users of psychiatric emergency services (Kessler & Lev-Ran, 
2019). Indeed, schizophrenia remains one of the greatest challenges for neuroscience, psychiatry, 
and health care systems as well as for patients and their families (Nutt & Need, 2014). 
Specifically, the etiology and pathophysiology of schizophrenia remain elusive and as such 
clinical diagnosis relies solely on subjective reports with no objective measures (e.g., 
biomarkers/laboratory tests) available to confirm or support diagnosis; nonetheless, objective 
measures are helpful in ruling out other possible causes (e.g., substance-induced psychosis or 
medical conditions).  
Furthermore, although the illness is considered to be largely genetic, more than 100 loci 
on different chromosomes have been identified, making the identification of specific disease-
causing pathways extremely complex. The absence of definite underlying causes prevents 
advancements in treatment. There have been limited improvements in pharmacological treatment 
since the development of second-generation antipsychotics in the 1980’s. Thus far, psychotropic 
medications are specifically aimed at symptom management and are not a cure. While symptoms 
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respond moderately to antipsychotic medications, pharmacological intervention can cause 
unwanted side effects and approximately 30% of patients are treatment-resistant (defined as 
being nonresponsive to two or more trials of antipsychotic medications despite adequate dose 
and duration; Vita et al.; 2019). 
For this reason, there continues to be an abundance of research aimed at understanding 
the neuropathophysiology of the disorder to better develop targeted treatment(s) to improve 
clinical symptoms and functional outcome. It is understood that schizophrenia, like other 
neurological disorders, is a result of abnormalities that subsequently cause disruptions in 
psychological (including cognitive) and social functioning. Several hypotheses have attempted to 
explain the underlying brain pathology. Here, we begin with an exploration of two of these 
hypotheses (neurodevelopmental and dysconnectivity) and the corresponding evidence to-date, 
paying specific attention to biological and psychological (particularly neuropsychological) 
factors. Consequently, the current study’s hypotheses and research aim are outlined; the goal is 
to assist in identifying the neuropathophysiological anomalies of this debilitating illness. An 
investigation of social factors is beyond the scope of this paper and is thus not addressed here. 
Considering Biological Factors  
Neurodevelopmental Hypothesis 
Evidence for understanding schizophrenia as a neurodevelopmental disorder emerges 
from both genetic and neuroimaging studies that suggest that early abnormal brain development 
may in part predispose individuals to developing the illness (Birnbaum & Weinberger, 2017). It 
is held that the genetic abnormalities in conjunction with prenatal and perinatal environment 
(such as maternal nutrition, gestational insults, and/or infection) impact brain development and 
mediate the clinical expression of schizophrenia in early adulthood. Current investigations 
4 
 
suggest that schizophrenia is a polygenic disorder and cannot be reduced to one gene. The most 
compelling genetic evidence comes from monozygotic and dizygotic twin studies (and other 
family studies) that show that genetic relatedness is the highest predictor of the illness, with 
estimated heritability rates up to 80% (Birnbaum & Weinberger, 2017). Furthermore, genetic 
linkage studies identified numerous putative genetic variants in susceptibility loci that influence 
risk (Birnbaum & Weinberger, 2017; Murray, Bhavasar, Tripoli, & Howes, 2017).  
Further genetic evidence that points towards a neurodevelopmental understanding of 
schizophrenia includes findings that similar genomic variations seen in known 
neurodevelopmental disorders (e.g., autism and mental retardation) are also observed in 
individuals with schizophrenia, though at a later developmental stage (i.e., at 3 years of age 
versus 18 years, respectively). During prenatal life, cell proliferation and migration occur as part 
of the normal development of the cortex while ongoing arborization and myelination occur 
postnatally throughout the first two decades of life. There is some evidence of arrested cell 
distribution in schizophrenia, suggestive of changes in density and distribution in different 
regions rather than fewer neurons (Insel, 2010). Thus, schizophrenia may result from excessive 
pruning of excitatory synapses, reduced inhibitory synapses, and reduced myelination. As a 
result, these early brain developmental abnormalities may disrupt the postnatal development of 
the neural circuitry of brain regions that reach maturity in early adulthood (e.g., the prefrontal 
cortex; Birnbaum & Weinberger, 2017).  
Supporters of the neurodevelopmental model argue that, in the context of earlier brain 
abnormalities, a confluence of maturational and environmental factors most likely contribute to 
the clinical expression of the disorder during the period of adolescence (Birnbaum & 
Weinberger, 2017). Findings from animal studies support the neurodevelopmental hypothesis in 
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that prenatal cortical lesions can cause behavioural and neurobiological abnormalities in late 
adolescence to early adulthood (Birnbaum & Weinberger, 2017). In late adolescence, 
myelination and other late maturational processes co-occur at the time of stress hormone changes 
and environmental stressors. The illness onset occurs between 18-25 years of age at a time period 
marked by significant physical and behavioural changes that are typically linked to underlying 
changes in the brain (including aberrant synaptic pruning and cortical thinning; Insel, 2010; 
Murray et al., 2017).  
Supporters of the neurodevelopmental model acknowledge that abnormalities occur 
during several developmental stages (i.e., fetal life, childhood, and adolescence) and interact 
with other risk factors (Murray et al., 2017). The presence of and possible interaction between 
the physical, behavioural, and neurobiological changes points to potential biopsychosocial 
influences that give rise to the expression of the illness during a particular developmental stage. 
The evidence suggests that these psychosocial influences can double or triple the risk of 
developing schizophrenia; these influences include being born and/or raised in urban settings, 
ethnic minority status (not dependent on recent migration), social exclusion/adversity, and/or 
cannabis use (Os, Kenis, & Rutten, 2010; Vassos, Pederson, Murray, Collier, & Lewis, 2012). A 
dose-response relationship exists between urbanicity (as measured by population size or density) 
and risk of developing schizophrenia (van Os et al., 2010). Thus, while heritability continues to 
be the strongest illness predictor, individual genetic variants have small effect sizes suggestive of 
a minor role for gene variants in susceptibility (Birnbaum & Weinberger, 2017), and growing 
evidence supports the interaction between genes and chronic psychosocial stressors that 
contribute to the manifestation of psychotic symptoms. It may be that genes mediate the risk of 
the illness by increasing the sensitivity to environmental factors (Misiak et al., 2019). 
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Additional genetic evidence comes from longitudinal studies (e.g., Copenhagen and 
Dunedin birth cohorts) which revealed that the developmental history of individuals who later 
progress to schizophrenia frequently include delays in achieving motor, language, and social 
developmental milestones during the first year of life as well as lower IQ scores during 
childhood (Murray et al., 2017; Ordóñez, Luscher, & Gogtay, 2016). Neuroimaging 
investigations reveal evidence of cortical thinning as well as significant progressive gray matter 
loss in childhood-onset schizophrenia and adolescence suggestive of a neurodevelopmental 
process specific to the illness that occurs even prior to medication exposure (see Ordóñez, 
Luscher, & Gogtay, 2016 for a review). Of note, while subtle cortical thinning may be observed 
in nonschizophrenic psychotic disorders, excessive gray matter loss seems to be associated with 
schizophrenia illness in particular and not due to IQ- or medication effects. 
The neurodevelopmental model of schizophrenia therefore purports that the observed 
symptoms of the illness during adolescence mark a late stage of the disorder rather than true 
onset per se. It has been previously proposed that there are 4 disease stages secondary to changes 
that occur in prenatal or perinatal life. Stages 1 to 4 mark a transition from risk (genomics, 
environmental factors, epigenetics) to prodrome (ultra-high risk or pre-psychosis phase typically 
remarkable for attenuated symptoms such as mild delusional thoughts or suspiciousness and 
impaired social and academic functioning) to psychosis (symptoms) to chronic disability (Insel, 
2010). However, research is needed to find more compelling evidence for the earliest stage (e.g., 
genetic and epigenetic biomarkers, cognitive predictors, etc.). While prodromal symptoms 
increase the predictive power of future development of schizophrenia, prodrome is a poor illness 
predictor overall because it is nonspecific (Insel, 2010; Woodberry, Shapiro, Bryant, & Seidman, 
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2016). In fact, many adolescents with similar symptoms either do not develop schizophrenia or 
develop other psychological illnesses.  
The neurodevelopmental model takes into account that events during adolescence may 
also increase the risk of schizophrenia. Nonetheless, current views support a Developmental Risk 
Factor Model rather than the neurodevelopemental model’s reductionistic approach in attributing 
the illness to disruptions in neurodevelopment. The Developmental Risk Factor Model purports 
that an increase in adverse life events (including victimization and trauma) as well as excessive 
drug use during adolescence are contributory to psychotic symptoms, especially delusional 
thinking (Murray et al., 2017). This more recent model also better accounts for evidence of 
neurodegeneration in schizophrenia.  
Dysconnectivity Hypothesis 
Another supported hypothesis is that schizophrenia is a dysconnectivity syndrome 
whereby symptoms emerge from abnormal connections between brain regions rather than 
region-specific abnormalities (Pettersson-Yeo, Allen, Benetti, McGuire, & Mechelli, 2011). 
Brain networks make up not only the brain regions involved in a particular function, but also the 
connections (or “edges”) that make synchronized activity between isolated regions (or “nodes”) 
possible (van den Heuvel & Fornito, 2014; Sporns, 2011). It has been suggested that aberrant 
connections exist between schizophrenia brain regions causing functional disintegration that 
underlies the psychopathological symptoms (Brandl et al., 2019). Since the early 1990’s, 
functional neuroimaging data continue to provide evidence for dysconnectivity between and 
within key brain regions among individuals with schizophrenia irrespective of chronicity and 
diagnostic subgroups (Pettersson-Yeo et al., 2011).  
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Within the last decade, a growing number of investigators have been attempting to find 
psychosis-specific structural correlates of functional dysconnectivity and/or distinct white mater 
abnormalities (Pettersson-Yeo et al., 2011). Advances in magnetic resonance imaging (MRI) 
techniques provide non-invasive ways to investigate the structural anatomical changes 
underlying brain diseases like schizophrenia, to further the understanding of pathological 
processes. Two structural imaging analyses often used in schizophrenia research are diffusion 
tensor imaging (DTI) and measures of cortical thickness. DTI allows for the investigation of 
structural connectivity by examining commonly reported measures such as fractional anisotropy 
(FA), mean diffusivity (MD), and radial diffusivity (RD). These three measures provide 
complementary information on the integrity of overall white matter microstructure.  
Fractional anisotropy is considered the most sensitive measure of the underlying 
microstructure and provides information on the degree to which the diffusion of water molecules 
is constrained. Thus, myelinated axons (white matter) with good structural integrity have high 
FA values, reflective of their ability to permit one-directional water diffusion along cells, while 
restricting movement across cells. FA values are indicative of relative axonal size, myelination, 
axon connections, and orientation or direction of fibres such that lower regional FA values are 
suggestive of reduced axonal connectivity and white matter structural integrity due to lower axial 
(parallel) and/or higher radial (perpendicular) diffusivity (Alexander, Lee, Lazar, & Field, 2007). 
Given that axonal connectivity and myelination independently contribute to anisotropy, FA is 
sensitive, but nonspecific to the type of microstructural pathological changes (e.g., radial or 
axial; Alba-Ferrara & Erausquin, 2013). Specifically, radial diffusivity indexes myelin damage 
(i.e., increase RD reflects demyelination), while axial diffusivity indexes axonal injury. For this 
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reason, incorporating several diffusion measures may help to provide greater specificity or 
characterization of tissue structure/neuropathology (Alexander et al., 2007).  
MD and FA typically have an inverse relationship. MD is a measure of the mean 
diffusion of water in all directions, and thus higher values are found in regions with 
unconstrained motion (e.g., cerebrospinal fluid and in neurons with compromised myelination). 
MD is particularly sensitive to edema, necrosis, and cellularity. RD is considered an indirect 
measure of overall myelin integrity as it reflects the diffusion of water molecules perpendicular 
to the primary axis of the diffusion ellipsoid. RD increases with reduced myelination and can 
also be affected by the density or diameter of axons. The evidence thus far suggests that reduced 
structural network connectivity of large-scale white matter tracts may be implicated in the 
development of schizophrenia illness, particularly those projections between frontal, temporal, 
and parietal brain areas (van den Heuvel & Fornito, 2014).  
Functional connectivity and structural (i.e. white matter) integrity are closely related 
(Hermundstad et al., 2013). In fact, either structural or functional connectivity is used to measure 
hypo- or hyperconnectivity. The integrity of brain regions and networks provides a good estimate 
of the quality of functional integration between networks, suggesting that anatomical patterns 
underlie functional connectivity (Nelson, Bassett, Camchong, Bullmore, & Lim, 2017). Of note, 
the anatomical integrity of one region directly influences regions with which it is structurally and 
functionally connected (Wheeler & Voineskos, 2014).  
Cortical thickness is a sensitive imaging measure used to detect alterations in brain 
structure that may give rise to psychotic illness and cognitive impairment. The thickness of the 
cerebral cortex is dependent on the density, structure, and arrangement of neurons and glial cells 
(Garey, 2010). Current views hold that schizophrenia involves reductions in whole-brain volume 
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and cortical thickness most consistently in the prefrontal, temporal, and parietal regions (Menon, 
2011; Olabi et al., 2011; Woodward et al., 2015). A recent meta-analytic study supports previous 
findings of widespread cortical thinning in individuals with schizophrenia in comparison to 
control volunteers, though there were some brain regions with relatively thicker cortex (van Erp 
et al., 2018). It is noteworthy that thicker cortex is not always indicative of better functioning; 
indeed, thinner cortex may be suggestive of “efficient neural organization and learning-
dependent plasticity” (Meyer, Liem, Hirsiger, Jäncke, & Hänggi, 2014).  
Abnormal structural (and functional) network connectivity has also been shown in 
individuals with schizophrenia in the fronto-temporal, fronto-parietal and fronto-striatal networks 
(Nelson, Bassett, Camchong, Bullmore, & Lim, 2017). These abnormalities may partially 
explain why those with the illness and comparison controls have been found to use dissimilar 
brain regions to complete the same cognitive task (e.g., executive functioning tasks; Tan et al., 
2006). Currently, a meta-analytic study conducted by Brandl and colleagues provides cutting-
edge evidence of substantial dysconnectivity as a result of both alterations in functional 
connectivity and brain structure (Brandl et al, 2019). Specifically, the presence of functional 
dysconnectivity combined with diminished gray matter volume (GMV) in particular brain 
regions (i.e., insula, lateral postcentral cortex, striatum, and thalamus) among individuals with 
schizophrenia is suggestive of dysfunctional brain regions that can be targeted for 
pharmacological and behavioural treatment. Thus, GMV and functional dysconnectivity (hyper- 
or hypoconnectivity) overlap in a bi-directional way at least in particular brain areas. 
Nonetheless, these imaging findings may reflect pathophysiology related to both the cognitive 
and psychotic features of schizophrenia (i.e., positive and negative symptoms).  
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Psychological Factors: Cognition as a key disease feature  
Although cognitive impairment is not included in the diagnostic criteria of schizophrenia, 
it is a core feature of the disorder affecting approximately 75% of patients. Research studies have 
highlighted the importance of cognition (including social cognition) in not only separating 
individuals with schizophrenia from controls (Heinrichs, 2005), but also in its influence on 
community functioning (see Fett, Viechtbauer, Dominguez, Penn, van Os, & Krabbendam, 2011 
for a meta-analytic review). Previous evidence suggested that neurocognitive functioning 
accounted for approximately 60% of functional outcome variance (defined as community 
outcome, social problem-solving, and psychosocial skill acquisition; Green, Kern, Braff, & 
Mintz, 2000); though recent findings suggest more modest effects (i.e., 4-23%; Fett et al., 2011).  
Nonetheless, cognitive impairment is typically observed in the domains of attention, 
processing speed, learning and memory, problem-solving, and social cognition (e.g., perspective-
taking, emotion recognition and management; Wei, Wang, Yan, Li, Pan, Cui, Su, Liu & Tang, 
2015). On average, patients perform approximately one standard deviation below control groups 
on cognitive measures (Heinrichs, 2005). Meta-analytic findings suggest that the most common 
neuropsychological abilities affected include attention and working memory, phonemic word 
fluency, verbal learning and memory, and aspects of executive functioning (i.e., abstract 
reasoning and mental flexibility), which have the largest effect sizes (d ³ 1; see Heinrichs, 2005 
for review). Evidence from systematic reviews and a meta-analytic study suggest that attention 
and vigilance, verbal fluency, verbal learning and memory, and executive functioning, as well as 
processing speed and visual learning and memory are linked to functional outcome (Fett et al., 
2011; Green, 1996; Green et al., 2004). However, the utility of examining domain-specific 
relationships to functional outcome is questionable given that the difference between these effect 
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sizes tend to be relatively small with overlapping confidence intervals (Fett et al., 2011).  
Specifically, given that there is generalized cognitive impairment in schizophrenia, selective 
deficits are influenced by this broad background impairment and may be difficult to observe. 
While the majority of individuals with schizophrenia are cognitively impaired, there is no 
biological abnormality that occurs consistently in a majority of patients (Birnbaum & 
Weinberger, 2017). Additionally, there is no unique neuropsychological profile that defines 
schizophrenia or that has been definitively linked to a specific concomitant biological 
abnormality. Nonetheless, cognition is very sensitive to the presence of the illness; indeed, 
distribution overlap is greater with neuroimaging than with neurocognitive performance 
(Heinrichs, 2005). Of note, medications typically attenuate positive symptoms but do little for 
cognitive and negative symptoms (Fusar-Poli et al., 2014; Nielsen et al., 2015); and both 
cognitive and negative symptoms contribute to significantly poor functional outcome (Fusar-Poli 
et al., 2014).  
However, a minority of patients (15-25%) demonstrate average to superior ability on 
many standard cognitive measures with no attenuation of the severity of psychotic symptoms  
(Ammari, Heinrichs, & Miles, 2010; Heinrichs et al. 2008; Muharib, Heinrichs, Miles, Pinnock, 
McDermid Vaz, & Ammari, 2014; Palmer et al., 1997) and little or no functional advantage in 
the community even with supports (Ammari, Heinrichs, Pinnock, Miles, Muharib, & McDermid 
Vaz, 2014; Muharib et al., 2014) . The data imply a dissociation of cognitive and psychosis-
generating neural mechanisms. It may be that these patients share a disease process that leads to 
psychosis but vary in terms of the pathophysiology that causes cognitive impairment. If this 
conjecture holds true, the inclusion of patients with relatively intact cognitive functioning in 
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research studies provides a unique opportunity to investigate the possible origins of psychosis in 
the brain, without the obscuring influence of cognitive pathology.  
It is known that a subset of community-dwelling neurologically normal individuals 
performs below average limits on neurocognitive measures (Schretlen, Testa, Winicki, Pearlson, 
Gordon, 2008), but they are seldom included in schizophrenia research. Schretlen and colleagues 
found that 13-19% of control participants obtained demographically and estimated premorbid 
IQ-adjusted T-scores below 40 (1 SD below the mean), and up to 6% approximately had scores 2 
SDs below the mean across 43 cognitive measures. Cognitive performance among the patient 
population, akin to the control population, may be on a continuum. In this respect, the presence 
of cognitive impairment is not a pathognomonic sign of schizophrenia illness. However, the 
majority of research findings to-date are obscured by data typically collected from and 
comparing cognitively impaired patients with cognitively normal nonpsychiatric controls. A 
meta-analysis of functional imaging studies conducted by Minzenberg and colleagues revealed 
that only 8 of the 41 studies matched controls and individuals with schizophrenia on cognition 
(Mizenberg, Laird, Thelen, Carter, & Glahn, 2009). The problem is, if cognition and psychosis 
reflect different effects on brain processes and structure, the failure to include both patients and 
controls with and without cognitive impairment precludes the investigation of these differential 
effects. Thus, the inclusion of both cognitively normal patients and below-average controls in 
schizophrenia research may elucidate the structural brain differences attributable to 
schizophrenia psychopathology and not due to cognitive impairment. 
It is noteworthy, however, that cognitive normality in schizophrenia remains a 
controversial topic, and some researchers contest its existence. There is evidence to suggest that 
despite some patients’ current average cognitive performance profile, there are at least some 
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whose level of performance is a reduction from above-average premorbid functioning (Allen et 
al., 2003). Still others argue against cognitive normality in schizophrenia in light of the existence 
of performance deficits on some cognitive measures (e.g., psychomotor abilities and executive 
functioning) as compared to controls (Heinrichs et al., 2015; Wilk et al., 2005). However, 
patients’ and controls’ performance are not always discrepant (Heinrichs et al., 2008; Muharib et 
al., 2014), and it is perhaps reasonable to expect some dissimilarities in performance between 
patients and controls given the illness burden. The existence of cognitive variability necessitates 
inquiry as this may contribute to the understanding of the neuropathologic heterogeneity of 
schizophrenic illness. 
Taken together, the study of patients with normatively average-range neuropsychological 
performance profiles at time of testing, including those with putative deterioration from higher 
premorbid levels, has implications for understanding the neural mechanisms underlying 
psychotic disorder and its effects on real-world functioning (Shamsi et al., 2011). One such 
implication of poor functionality in cognitively normal patients is that perhaps the field is wrong 
in its emphasis on cognition as the main driver of adjustment. Another explanation is that 
perhaps the level of cognitive proficiency required for basic daily functioning is not that high. Of 
course, both cognitive and daily functioning are in part dependent on intact brain systems 
integral for information processing, and thus impairments in functioning suggests cortical 
disruptions. 
Behavioural data suggest that cognitive impairment and psychosis are largely 
independent illness processes (de Gracia Dominguez et al., 2009; Heinrichs et al., 2015), while 
neuroimaging data are inconsistent. For instance, imaging data have shown reduced gray matter 
volumes in individuals with schizophrenia irrespective of cognitive status (i.e., cognitively 
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normal and below-normal range patients) indicating that the illness is associated with structural 
brain changes (Wexler et al., 2009; Heinrichs, Pinnock, Parlar, Hawco, Hanford & Hall, 2017). 
Other research findings suggest that it is white matter (not gray matter) abnormalities that are a 
hallmark of schizophrenia, affecting both neuropsychologically normal and impaired patients 
compared to controls (Woodward et al., 2015). More recent evidence from Czepielewski and 
colleagues (2017) adds further discrepant findings to the literature. These researchers used 
structural imaging techniques to examine both whole-brain and regionally specific areas in the 
frontal and temporal lobes (i.e., anterior cingulate cortex, anterior insula, and hippocampus) 
known to be affected in schizophrenia compared to comparison controls. The data revealed 
substantial structural brain abnormalities (including reduced total brain volume, intracranial 
volume, cortical gray matter volume, and cortical thickness) in cognitively impaired patients 
with little such structural changes observed in their cognitively normal counterparts 
(Czepielewski, Wang, Gama, & Barch, 2017).  
Towards a Network-Approach 
Nonetheless, more compelling evidence for illness-specific brain processes comes from 
network analyses that examine spatially distinct brain areas that function together (i.e., belong to 
a given brain network) rather than specific cortical regions. While previous views held that brain 
networks were disjointed, recent data highlight that the same brain regions may belong to more 
than one network simultaneously (Najafi, McMenamin, Simon, & Pessoa, 2016). Indeed, there 
has been an increase in using a network approach as it more appropriately accounts for cognition 
and behaviour, which depend on the complex exchange between brain regions that are 
functionally connected. Furthermore, region of interest analyses, avoid the problem of multiple 
comparisons and allow for greater statistical power (Lindquist & Mejia, 2015). Identifying 
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aberrant structural changes of key brain networks may pinpoint the pathological processes that 
give rise to problematic cognitive and psychological functioning. It is more plausible that a 
complex and debilitating disorder like schizophrenia results from abnormal functioning in 
interconnected brain regions as opposed to focal lesions in a few cortical areas (van den Heuvel 
& Fornito, 2014).  
Large-Scale Brain Networks 
The Relationship between the Default Mode and Central Executive Networks 
Key networks include the default mode network (DMN), salience network (SN), and 
central executive network (CEN). The default mode network (DMN) is active at rest and 
involved in processing internally-directed thoughts and feelings (Anticevic et al., 2012; Hu et al., 
2017). It consists of the posterior cingulate, precuneus, ventromedial prefrontal cortex, medial 
and lateral temporal lobes, inferior parietal lobule (angular gyrus), posterior extent of the inferior 
parietal lobule, as well as the superior and inferior frontal gyri (Spreng et al., 2013; Stevens & 
Spreng, 2013). The DMN is negatively correlated with the central executive network (CEN), 
which is engaged by goal-directed, externally-directed cognitive effort (i.e., higher-order 
cognitive and attentional control processes such as working memory, inhibitory control, problem 
solving, and mental flexibility; Hu et al., 2017; Menon & Uddin, 2010; Metzak et al., 2011). The 
primary CEN nodes include the dorsolateral prefrontal cortex (dlPFC), intraparietal sulcus (IPS), 
frontal eye field (FEF), anterior extent of the inferior parietal lobule (aIPL), medial superior 
prefrontal cortex (msPFC), anterior insular cortex and posterior parietal cortex (Menon, 2015; 
Spreng et al., 2013).  
An over-active DMN may produce psychopathology while also suppressing the CEN, 
leading to cognitive impairment (Anticevic et al., 2012; Hu et al., 2017). Evidence suggests that 
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an over-active DMN in schizophrenia patients not only correlates with impaired cognitive 
performance, but is also linked to greater psychopathology (e.g., positive symptoms such as 
hallucinations and delusions; Whitfield-Gabrieli & Ford, 2012; see Hu et al., 2017 for a review). 
However, from this perspective psychosis should associate invariably with cognitive impairment, 
a prediction contradicted by the discovery of cognitively normal patients. Research has found 
that there exists an inhibitory connection from the CEN to the DMN such that CEN-activation 
deactivates the DMN (Chen et al., 2013). The existence of patients with preserved cognition 
offers a unique opportunity to test the DMN/CEN model and to determine the neural correlates 
of psychosis as distinct from cognitive impairment in schizophrenia pathophysiology.  
The Salience Network 
The salience network (SN) is important for detecting salient information from among 
various competing stimuli to orient resources towards its processing (Bressler & Menon, 2010; 
Kim, 2014; Vossel, Geng, & Fink, 2014). This network is composed of the anterior insula, the 
dorsal anterior cingulate cortex, temporo-parietal junction, and subcortical regions including the 
amygdala, substantia nigra, and thalamus, and has been shown to control switching between the 
DMN and CEN (Menon, 2015; Menon & Uddin, 2010). Its interconnection with these key 
networks and role as a high-level multisensory integration system allows for its involvement in 
complex (social) cognitive functioning and initiation or modification of behaviour (e.g., self-
awareness, social interactions; Menon, 2015; Palaniyappan, L & Liddle, P., 2012). Disruptions in 
saliency can be observed among individuals with schizophrenia who typically misattribute the 
importance of internal and external sensations (Menon, 2015; Palaniyappan, L & Liddle, P., 
2012). Thus, an impaired DMN may lead to psychosis, while impaired DMN and SN lead to 
impaired cognition as well as psychosis.  
18 
 
The Social Brain Network 
Lastly, the social brain network (SBN) involves a number of brain regions important for 
processing social information (Grossman, 2013) and thus, the social cognitive deficits in 
schizophrenia. Social cognition includes social perception, emotion processing, attributional 
bias, and theory of mind (ToM, ability to infer another individual’s views or judgments; Green & 
Horan, 2010). Patients are significantly debilitated by deficits in social functioning, which is a 
good predictor of illness recovery and functional outcome (job attainment, interpersonal 
relationships, and managing instrumental activities of daily living; Dodell-Feder, Tully, & 
Hooker, 2015; Green, Lee, & Ochsner, 2013). Important SBN nodes include the anterior insula, 
amygdala, dorsomedial prefrontal cortex, temporo-parietal junction, the superior temporal 
sulcus, posterior cingulate cortex, and parts of the ventromedial prefrontal cortex (Kennedy & 
Adolphs, 2012). Muharib and colleagues (2014) found that cognitively normal patients 
outperformed cognitively-impaired patients on all cognitive measures except social cognition 
and were indistinguishable from cognitively-impaired patients with respect to dependence on 
social support systems. These findings highlight that preserved cognition may not translate to 
benefits in functional outcome.  
The Evidence on Structural Aberrations 
  The evidence suggests that large-scale brain networks are disrupted in schizophrenia (See 
Brandl et al., 2019 for recent meta-analysis). Heinrichs and colleagues (2017) recently published 
data indicating that cognitively normal controls have greater cortical thickness in key networks 
(i.e., default mode network (DMN), salience network (SN), but not the central executive network 
(CEN)) than cognitively normal and below-normal patients. However, there were no differences 
found between cognitively normal and below-normal controls or between cognitively normal and 
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below-normal patients (Heinrichs, Pinnock, Parlar, Hawco, Hanford & Hall, 2017). Thus, DMN 
and SN structural abnormalities may be related to the psychotic disease process and not to 
cognitive impairment.  
The dysconnectivity hypothesis (i.e., aberrant connections between brain regions) is 
mostly supported by findings of hypoconnectivity within and between key large-scale brain 
networks (e.g., between SN and DMN, SN and CEN, as well as between SN and key brain areas 
of the SBN like the amygdala) in patients when compared to control participants (Dong, Wang, 
Chang, Luo & Yao, 2017; Mukherjee et al., 2013). On the other hand, hyperconnectivity 
between and within some brain regions and circuits has also been reported (Wheeler & 
Voineskos, 2014; Mothersill et al., 2017). Hyperconnectivity between the DMN and SBN, for 
example, could give rise to impairment in social cognition and positive symptoms. Specifically, 
simultaneous activation of both circuits could cause increased salience of self-referential 
processes and poor perspective-taking (i.e., poor ToM; see Nekovarova, Fajnerova, Horacek, & 
Spaniel, 2014 for a review of large-scale network abnormalities related to self and ToM 
disturbances).  
As previously mentioned, neuroimaging findings comparing individuals with 
schizophrenia and controls have been largely inconsistent, with evidence reported of reduced 
connectivity particularly in frontal brain regions, as well as hyperconnectivity (e.g., among 
unmedicated patients at illness onset; Anticevic, 2015), or no difference (see Wheeler & 
Voineskos, 2014 for a review). A recent meta-analysis of resting-state functional and structural 
imaging data (fMRI and GMV) revealed more pronounced hypoconnectivity in the salience 
(SN), default mode (DMN), frontoparietal (FPN) or CEN, and limbic networks in the insula, 
thalamus, and striatum of individuals with schizophrenia compared to a community sample, 
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major depressive disorder, bipolar disorder, addiction, and anxiety disorder patient populations 
(Brandl et al., 2019). Furthermore, this study found hyperconnectivity within regions of the 
DMN, and between large-scale networks (e.g., limbic network and FPN or CEN) among 
individuals with schizophrenia in contrast to the same comparison groups. Thus, the study found 
hypoconnectivity between and across networks in DMN, SN, and CEN, and hyperconnectivity 
between DMN and the limbic network (Brandl et al., 2019). Of note, clinical or demographic 
variables (e.g., age, illness duration, symptom severity, medication) did not significantly impact 
dysconnectivity pattern (Brandl et al., 2019).  
The inconsistencies in findings suggest widespread, slight alterations in brain networks 
rather than obvious lesions in specific tracts (Wheeler & Voineskos, 2014). Tract-based 
differences are typically more variable between studies. Group differences are likely based in 
network approaches across the brain which tend to be more replicable (Wheeler & Voineskos, 
2014). Thus, the inconsistencies may simply reflect the heterogeneity of the disease within the 
study sample and/or whether the data were analyzed by particular subgroups. Furthermore, 
previous studies have focused on functional and/or anatomical connectivity, whole-brain volume 
or regional cortical thickness between large-scale brain networks in schizophrenia patients and 
controls. However, the field lacks a comparative investigation of these brain circuits and 
performance on neurocognitive measures between cognitively normal patients and controls. Such 
an approach would help clarify whether cognition and psychosis are indeed dissociable.  
Of course, an obstacle to identifying the independent contribution of structural 
abnormalities to cognitive impairment and psychosis is the co-existence of both in typical 
research samples. For this reason, the current study included patients who performed in the 
average to above average range, and control participants who performed in the below-average 
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range. Examination of both cortical thickness and white matter integrity across patient groups 
and between patients and controls will help to dissociate neurobiological correlates of cognitive 
impairment and psychosis. To date, no study has investigated the structural integrity of these four 
large-scale networks in cognitively normal individuals with schizophrenia compared to more 
typically cognitively impaired patients to take into account cognitive status. This project 
represents one approach to understanding the correlates of psychotic illness. This study 
investigated whether psychosis-specific networks are identifiable and dissociable from cognitive 
pathology and contribute to the understanding of heterogeneity within this complex disorder. 
Study Aim 
The main impetus for this study was to examine whether cognitively normal versus 
impaired patients have different structural connectivity patterns along tracts connecting core 
regions within and between four brain networks. Addressing this aim would further the 
understanding of whether psychotic illness and cognitive impairment represent separable yet 
comorbid disease processes. To this end, we asked: Are aberrations in cortical thickness and/or 
structural connectivity within and between networks associated with cognitive impairment and/or 
the severity of psychotic psychopathology at the time of this study? To answer this, we examined 
1) performance on standard consensus as well as adjunct specialized cognitive measures, 2) 
cortical thickness across the whole brain and within key large-scale brain regions (DMN, CEN, 
SN, SBN), and 3) the structural integrity of key white matter tracts; specifically the cingulum 
(CGC), genu of the corpus callosum (GCC), superior longitudinal fasciculus (SLF), sagittal 
stratum (includes the inferior longitudinal fasciculus and the inferior fronto-occipital fasciculus), 
and the uncinate fasciculus. Comparisons were made between schizophrenia patients and 
controls who met or failed to meet a cognitive normality criterion based on a widely used 
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neuropsychological test battery (Nuechterlein, et al., 2008).  
With respect to structural integrity, the white matter tracts studied were chosen on the 
basis of their connections to two key nodes (or brain regions) for each of the four networks. 
Specifically, key nodes for the DMN are the ventromedial prefrontal cortex (vmPFC) and the 
precuneus/posterior cingulate cortex (Uddin, Supekar, Ryali, & Menon, 2011). The cingulum 
bundle mediates the connection between these nodes (Bonnelle et al., 2012; De Simoni et al. 
(2016); Leech & Sharp, 2014; Menon 2013). The CEN’s core nodes are the posterior parietal 
cortex and the dorsolateral prefrontal cortex (Bressler & Menon, 2010; Uddin et al., 2011), and 
they are connected via the superior longitudinal fasciculus and genu of the corpus callosum 
(Wetherill et al., 2012). The anterior insula (AI) and dorsal anterior cingulate cortex (dACC) are 
crucial within the SN and communicate via the (ventral) uncinate fasciculus (Menon, 2015; 
Uddin et al., 2011). Lastly, the inferior longitudinal fasciculus and inferior fronto-occipital 
fasciculus (IFOF; together called the sagittal stratum (SS)) connects crucial SBN structures (i.e., 
amygdala, fusiform face area, and superior temporal sulcus; Jou et al., 2011).  
We were also interested in examining tracts that connect key nodes across networks. Of 
note, communication between key hubs across networks often rely on the same fibre tracts as 
within networks. The cingulum bundle allows key nodes within the CEN and DMN to exchange 
information as it connects the DLPFC and PCC (Heilbronner, & Haber, 2014). It also links key 
nodes of the SN (dACC) and DMN (PCC) (Heilbronner, & Haber, 2014). The key nodes of SN 
and CEN (i.e., AI and DLPFC, respectively) communicate via the fronto-occipital fasciculus 
(Uddin et al., 2011). The SN and CEN hubs (right AI and right PPC) are also linked through 
fibres from the superior longitudinal fasciculus (SLF; Supekar & Menon (2012). The SLF also 
connects the SN to the SBN through their key nodes (ACC and STS, respectively; see Wang, 
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Metoki, Alm, & Olson, 2018 for review). Lastly, the ventral cingulum bundle and inferior 
fronto-occipital fasciculus (IFOF) allows communication between the DMN and SBN via their 
key nodes, the PCC and amygdala (Wang et al., 2018). Taken together, the five tracts (cingulum 
bundle, superior longitudinal fasciculus, genu of the corpus callosum, uncinate fasciculus, and 
the sagittal stratum) were selected a priori for study inclusion based on previous research, 
reviewed below, that has established their role in allowing communication between and within 
networks. 
Key Functions of each Tract 
A recent meta-analytic study has confirmed findings of reduced structural integrity in 
these five tracts in schizophrenia, among others (Kelly et al., 2018). Interhemispheric and fronto-
temporal dysconnectivity are among the most consistent findings in schizophrenia research 
(Kelly et al., 2018). Among these, dysconnectivity of the genu of corpus callosum is an often 
replicated finding with one of the largest effects (Wheeler & Voineskos, 2014). Perhaps this 
tract’s importance lies in its role in interhemispheric communication in the prefrontal cortex 
region (typically impacted in schizophrenia). Studies support its reduced structural integrity as an 
enduring disease feature given its existence among individuals in the chronic or first-episode 
stage and those at high risk of developing the disease; it is involved in integrating behavioural, 
emotional, and cognitive information for processing and is linked to schizophrenia 
symptomatology (Di Biase et al., 2017; Kelly et al., 2018; Mike et al., 2013; Park et al., 2008). 
Reduced white matter integrity in the uncinate fasciculus has also been linked to social and 
neurocognitive impairment (e.g., impulsive responding/decision-making, poor long-term 
memory retrieval (particularly verbal memory), diminished emotional processing) as well as 
reduced functioning and possibly negative symptoms (Olson, Von Der Heide, Alm, & Vyas, 
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2015; Seitz et al, 2016).  Additionally, given the uncinate's role in allowing communication 
between the frontal and temporal (limbic) brain regions as well as its late maturation (i.e., into 
the third decade of life; Olson et al., 2015), it is unsurprising that it is found disrupted in patients.  
The superior longitudinal fasciculus is another tract of particular interest given its role in 
cognitive control and processing speed (Schaeffer et al., 2015; Turken et al., 2008). Studies have 
found reduced white matter integrity in both patients and comparison controls with poor 
cognitive control performance such as working memory (Karlsgodt, van Era, Poldrack, Bearden, 
Neurcheterlein, & Cannon, 2008; Schaeffer et al., 2015). Indeed, the SLF’s bidirectional fronto-
parietal connections may allow for its role in the top-down regulation needed for cognitive 
control (e.g., from prefrontal areas such as the dorsolateral prefrontal cortex to parietal regions 
such as the posterior parietal cortex; Schaeffer et al., 2015). Thus, superior longitudinal 
fasciculus may be an important tract to demonstrate the impact of cognitive deficit separate from 
that of psychotic psychopathology. On the other hand, the cingulum was not expected to 
differentiate cognitively normal and below-normal range patient groups given that this tract is 
involved in both psychotic symptoms and cognitive functioning (e.g., hallucinations, flat affect 
and anhedonia/asociality, emotional regulation, processing speed, and executive functions such 
as cognitive control; Bubb, Metzler-Baddeley, & Aggleton, 2018; Seitz et al., 2016; Whitford et 
al., 2014; Wisner et al., 2019). Lastly, aberrations in the sagittal stratum is associated with 
positive symptoms (e.g., auditory verbal hallucinations), facial recognition, and emotion 
perception (Jou et al., 2011; Oestreich, McCarthy-Jones, & Whitford, 2016; Seitz et al., 2016).  
Hypotheses 
Building on a program of research from the Heinrichs’ schizophrenia lab (Heinrichs et 
al., 2017; Muharib et al., 2014), it was hypothesized that 1) cognitively normal and below-
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normal range patients will have comparable severity of psychopathological symptoms; 2) on 
intellectual functioning, standard consensus (with the exception of performance on processing 
speed), and adjunct specialized cognitive measures, cognitively normal range patients and 
controls will have inappreciable differences in performance, both cognitively normal range 
groups will outperform the below-normal range groups, and below range patients and controls 
will have identical neurocognitive performance profiles; 3) cortical thinning patterns will be 
largely comparable between patient groups reflecting a common underlying psychopathology, 
with notable thinning in SN, DMN, and SBN when compared to cognitively normal controls.  
4) However, it was predicted that cognitively normal and below-normal range patients 
will have dissimilar white matter connectivity patterns between CEN and DMN (see Figure 1A 
and 1B) to account for the differing cognitive performance profiles in the patient groups. 
Specifically, we expected that cognitively below-average patients will have reduced connectivity 
between CEN and DMN as compared to cognitively normal patients. However, this could not be 
directly measured in our imaging analyses given that the same tracts allow communication 
between and within networks.  We hypothesized that both patient groups will have compromised 
white matter integrity across four tracts measured in this study given their associations to 
cognitive functioning and psychotic symptoms (i.e., genu of the corpus callosum, uncinate 
fasciculus, cingulum, and sagittal stratum), when compared with cognitively normal range 
controls. We predicted that below-normal range patients will have greater reductions than 
cognitively normal range patients (relative to cognitively normal range controls) given the 
presence of both disease processes in this group (i.e., cognitive impairment and psychotic 
symptoms). 
We hypothesized that the integrity of the superior longitudinal fasciculus will 
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differentiate the patient groups given this areas role in cognition. It was anticipated that there will 
be no difference between the cognitively normal range patients and controls. However, 
significant group differences were expected between the cognitively normal range groups and 
their below-normal range counterparts. Taken together, similarities found between cognitively 
normal range and below-normal range patients will highlight shared underlying neural 
mechanisms of the disease, while dissimilarities will pinpoint processes possibly linked 
specifically to cognitive impairment and/or comorbidity. It was predicted that whole-brain white 
matter integrity will be lower among patients than cognitively normal range controls, which has 
been consistently shown (Kelly et al., 2018). 
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Figure 1B. Cortical thickness and white matter connectivity in cognitively below-average schizophrenia patients. 
Dashed borders on boxes represent cortical thinning and solid borders are indicative of indistinguishable thickness from controls. Thin lines index reduced connectivity 
and thick lines suggest intact (or hyper-) connectivity between networks relative to cognitively normal controls. dACC: dorsal anterior cingulate cortex; AI: anterior 
insula; Amyg: amygdala; STS: superior temporal sulcus; FFA: fusiform face area; SS: sagittal stratum (inferior longitudinal fasciculus (ILF) and inferior fronto-occipital 
fasciculus (IFOF)); vmPFC: ventromedial prefrontal cortex; PCC: precuneus/posterior cingulate cortex; dlPFC: dorsolateral prefrontal cortex; PPC: posterior parietal 
cortex; SLF: superior longitudinal fasciculus; GCC: genu of the corpus callosum.
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Figure 1A. Cortical thickness and white matter connectivity in cognitively normal schizophrenia patients. 
Dashed borders on boxes represent cortical thinning and solid borders are indicative of indistinguishable thickness from controls. Thin lines index reduced connectivity 
and thick lines suggest intact (or hyper-) connectivity between networks relative to cognitively normal controls. dACC: dorsal anterior cingulate cortex; AI: anterior 
insula; Amyg: amygdala; STS: superior temporal sulcus; FFA: fusiform face area; SS: sagittal stratum (inferior longitudinal fasciculus (ILF) and inferior fronto-occipital 
fasciculus (IFOF)); vmPFC: ventromedial prefrontal cortex; PCC: precuneus/posterior cingulate cortex; dlPFC: dorsolateral prefrontal cortex; PPC: posterior parietal 
cortex; SLF: superior longitudinal fasciculus; GCC: genu of the corpus callosum.
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Methods 
Participants 
Patients (n = 73) were recruited from active outpatient rehabilitation programs in 
Hamilton, Ontario, Canada and include the Cleghorn Early Intervention Clinic (St. Joseph’s 
Healthcare Hamilton), the Hamilton Program for Schizophrenia, the Schizophrenia Outpatient 
Clinic (St. Joseph’s Healthcare Hamilton), Schizophrenia Services of Ontario, Hamilton Chapter, 
Path Employment Services and the Wellington Psychiatric Outreach Program. Criteria for 
participation in the study included: 1) a diagnosis of schizophrenia or schizoaffective disorder 
confirmed by the Structured Clinical Interview for DSM-IV Axis I Disorders (First et al., 1996), 
with no concurrent diagnosis of substance use disorder; 2) a history free of developmental or 
learning disability; 3) a history free of neurological or endocrine disorder; and 4) being between 
age 18–65 years. Comparison control participants (n = 64) were recruited through local 
newspaper and online classified advertisements for paid research participation. Furthermore, 
advertisements targeting community, employment and social service agencies that cater to 
unskilled and less educated populations were utilized to maximize the recruitment of control 
participants with below-normal range cognitive functioning. Interested individuals were screened 
to rule out a history of neurological, endocrine, psychiatric, or substance use disorders. All 
participants were required to be free of MRI contraindications, were given monetary 
compensation for their time, and provided their written informed consent. The research was 
approved by York University and St. Joseph’s Healthcare Hamilton ethics review boards and in 
compliance with the Helsinki Declaration. 
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Clinical Measures 
Medical charts were reviewed for individuals with schizophrenia to verify class of 
antipsychotic medication(s) and their dosages, as well as document other psychotropic 
medications taken at the time of the study. Additionally, the Social and Psychiatric History 
Schedule was used to document patients’ demographic information (i.e., age, education, marital 
status, and employment history) and psychiatric history. Clinical symptom severity was 
measured with the 30-item Positive and Negative Syndrome Scale (PANSS; Opler, Kay, 
Lindenmayer, & Fiszbein, 1999) via a semi-structured clinical interview to assess positive, 
negative, and general psychotic symptoms. Positive symptoms as assessed on the PANSS 
positive scale include delusions, conceptual disorganization, hallucinations, grandiosity, 
suspiciousness or persecution, hyperactivity, and hostility. The severity of negative symptoms is 
expressed on the PANSS negative scale as blunted affect, emotional and social withdrawal, poor 
rapport, difficulty in abstract thinking, and stereotypic thinking. Lastly, the general scale is a 
measure of global psychopathology and is comprised of poor insight and judgment, 
disorientation, unusual thought content, poor attention, depression, anxiety, feelings of guilt, 
motor retardation, and somatic concern. A composite score reflects the difference between the 
positive and negative scores. PANSS scales are rated on a 7-point Likert scale to capture a range 
of symptoms classified as absent to extreme psychopathology.  
Neurocognitive Measures 
The MATRICS (Measurement and Treatment Research to Improve Cognition in 
Schizophrenia) Consensus Cognitive Battery (MCCB; Nuechterlein et al., 2008) was 
administered to assess cognitive abilities typically found disrupted in schizophrenia and 
schizophrenia-related disorders. The MCCB was developed by experts as a consensus among the 
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academic community and the National Institutes of Health (NIH) to include in the battery 
individual measures of processing speed (Category fluency, Symbol coding, Trail making A), 
attention/vigilance (Continuous Performance Test, Identical Pairs [CPT-IP]), working memory 
(Letter-Number Sequencing [WAIS-III], Spatial Span [Wechsler Memory Scale III]), verbal 
learning (Hopkins Verbal Learning Test-Revised), visual learning (Brief Visuospatial Memory 
Test-Revised), reasoning and problem solving (Mazes (Neuropsychological Assessment Battery 
[NAB]), and social cognition (Mayer-Salovey-Caruso Emotional Intelligence Test [MSCEIT] – 
Managing Emotions), which yields a composite index of overall performance. The MCCB was 
developed to provide a consensus battery of neurocognitive measures in schizophrenia that were 
amenable to change and would thus be suitable targets for cognitive remediation and treatment. 
The MCCB assesses key modifiable cognitive domains and captures more cognitive variance 
than IQ alone (August, Kiwanuka, McMahon, & Gold, 2012; Nuechterlein et al., 2008). 
Standard measures of general intellectual ability were also included to assess 
participants’ verbal and visual skills. The Vocabulary and Matrix Reasoning subtests of the 
Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999) were used to provide a 
robust estimate of general intelligence (or intelligence quotient (IQ); Alwin & McCammon, 
2001). Indeed, verbal ability tends to measure crystallized intelligence, which typically 
withstands psychiatric illness (Sheppard & Vernon, 2008). For the WASI Vocabulary subtest, 
participants were asked to generate definitions to words whereas the Matrix Reasoning subtest 
was used to assess participants’ visual reasoning skills required to accurately complete 
sequencing patterns. The Reading subtest of the Wide Range Achievement Test (WRAT-4; 
Wilkinson & Robertson, 2006), another test of verbal ability, was used to estimate premorbid 
intellectual ability. For this task, participants were asked to read words that became increasingly 
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challenging to pronounce due to their phonological complexity and infrequency. It is considered 
an indicator of premorbid functioning because the skill of decoding words is typically learned 
prior to disease onset and is less susceptible to psychiatric and neurological illness (Nelson & 
O’Connell, 1978; Bright & van der Linde, 2018). Of note, other cognitive measures (e.g., 
processing speed, working memory, declarative memory) are vulnerable to the underlying 
psychiatric disease process (Nuechterlein, Barch, Gold, Goldberg, Green, & Heaton, 2004). 
Adjunct measures of social cognition included Theory-of-Mind or reasoning about the 
mental states of a person, as measured by the Faux Pas Recognition Test (Stone, Baron-Cohen, 
& Knight, 1998) and the Reading the Mind in the Eyes test (Baron-Cohen, Wheelwright, Hill, 
Raste, & Plumb, 2001). The Faux Pas Recognition Test requires that participants listen to short 
stories and infer whether a character unintentionally committed a faux pas against another 
causing embarrassment. The Reading the Mind in the Eyes test is a visual task that involves 
inferring thoughts and emotions from photographs of a person’s eyes. Theory of mind has been 
linked to positive symptoms (e.g., paranoid delusions) and symptoms of disorganization such 
that individuals with these symptoms tend to be significantly impaired in their ability to infer 
others’ mental states (i.e., thoughts, beliefs, and intentions) “to explain, manipulate and predict 
behaviour” (Brüne, 2005; Dudley, Taylor, Wickham, & Hutton, 2016; Kinderman & Bentall, 
1996; Sprong, Schothorst, Vos, Hox, van Engeland, 2007). 
The “beads” task was used to measure faulty decision-making in probabilistic reasoning 
(“jumping to conclusions”; Garety & Freeman, 2013). In this task, participants are required to 
decide from which of 2 “jars” individually-presented colored “beads” were drawn. The jars 
contained either a 60:40 ratio of red to blue beads or blue to red beads, and the number of trials 
taken to decide was the dependent variable. Meta-analytic studies provide some support for the 
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sensitivity of the beads task to psychotic psychopathology, particularly in individuals with 
delusions; though there is some suggestion that other variables may mediate or account for these 
findings (e.g., general intellectual ability; So, Siu, Wong, Chan, & Garety, 2016; Ross, McKay, 
Coltheart, & Langdon, 2015).  
Group Assignment 
Patients and controls were assigned to the cognitively normal or below-normal range 
based on their MCCB T composite score, an index of their overall performance on the 7 domains 
(i.e., working memory, attention, verbal memory, processing speed, reasoning and problem-
solving, visual learning, and social cognition). Group assignment was carried out using the 
criterion of a T score of 50 ± 10, which represents a normative mean performance in a 
standardized distribution. Thus, participants who performed in the range of 40 to 60 were 
assigned to the cognitively normal range group, and those with performances lower than 40 were 
assigned to the below-normal range groups, consistent with group assignment criteria completed 
in other studies (Heinrichs et al., 2015; Muharib et al., 2014). The resulting group compilation 
was such that there were 16 cognitively normal and 48 cognitively below-normal schizophrenia 
patients as well as 36 cognitively normal and 21 below-normal controls. Thus, this study sample 
included 121 participants (N=121). 
Scan Acquisition 
Structural magnetic resonance imaging and diffusion tensor (MRI and DTI) were 
collected for all participants. Magnetic resonance images were acquired using a 3.0 Tesla whole 
body short bore General Electric System scanner equipped with an 8-channel parallel receiver 
head coil at St. Joseph’s Healthcare Hamilton, in Hamilton, Ontario, Canada. High-resolution 
T1-weighted axial anatomical images were collected with a 3D fast-spoiled gradient-echo 
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sequence resulting in 152 slices using the following parameters: slice thickness = 2mm, with 1 
mm overlap, time to repetition (TR) = 7.5ms, time to echo (TE) = 2.1ms, flip angle = 12ᵒ, 
number of excitations (NEX) = 1, field of view (FOV) = 24 cm, acquisition matrix = 512 x 512, 
and receiver bandwidth (rBW) = +/−62.5 kHz. DTI was conducted using a spin echo planar 
imaging sequence with 5 b=0 volumes and 29 noncolinear diffusion directions at b = 1000s/mm2. 
Fifty-three axial slices were acquired (2.4mm thick, no gap) for full brain coverage, using the 
following imaging parameters: TR/TE = 15000/85.9ms, FOV = 24cm, matrix = 128 x 128, rBW 
= +/-250kHz. The DTI image acquisition was repeated to achieve the effect of 2 NEX.  
Preprocessing 
For cortical thickness, cortical surface reconstruction and thickness were calculated using 
Freesurfer’s automated processing pipeline (version 5.1.0, http://surfer.nmr.harvard.edu). A full 
description of this technique has been described (Dale, Fischl, & Sereno, 1999; Fischl & Dale, 
2000). Preprocessing procedures commenced with skull stripping, motion correction, and spatial 
and intensity normalization. Subsequently, a surface-based tessellation of gray matter/pial and 
gray matter/white matter boundaries were generated across 160,000 vertices in each hemisphere. 
Surface reconstruction was then visually inspected (slice-by-slice) for accuracy, and manual edits 
were repeatedly performed to correct inaccuracies until the inspection of the scan was 
acceptable. Images were then registered to a high-dimensional spherical average to align cortical 
folds across subjects. Cortical thickness was calculated as the shortest distance between the pial 
surface to the gray/white matter border at each vertex, and maps were smoothed using a 10mm 
full-width-half-maximum Gaussian kernel. Data processing was completed by an imaging expert 
collaborator who was blind to the subject group.  
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Tract-based spatial statistics (TBSS) allows for nonlinear alignments and projections of 
tracts onto average tract representations, which allows for voxel-by-voxel group comparisons on 
diffusion parameters. Specifically, DTI data were preprocessed with FSL 5.0.6 (FMRIB 
Diffusion Toolbar and TBSS software tools; Smith et al., 2006). Data were first corrected for 
head movement and eddy currents using FMRIB’s Diffusion Toolbox (FDT), followed by 
application of brain-extraction to each image with the Brain Extraction Tool (also found in FSL; 
Smith, 2002) to differentiate the brain from skull structures and extract FA values throughout the 
brain. Subsequently, each voxel within the brain mask was fitted to a tensor model. FMRIB’s 
FLIRT and FNIRT (the linear and nonlinear registration tools, respectively) were utilized to 
align the FA data into the Montreal Neurological Institute’s (MNI-152 1mm3) standard space. 
Consequently, a mean FA skeleton image (thresholded at FA ≥ 0.2) was created from voxels 
found at the centres of major white matter tracts. TBSS thus ensures that common tracts are not 
formed from voxels within the distal extremes of white matter tracts that have greater 
intersubject variability, that is, where FA values would be compromised by poor registration or 
volume effects (such as areas close to the CSF or grey matter). Each participant’s aligned FA 
images were mapped onto the mean FA skeleton image in the common MNI space. Lastly, 
voxel-wise group statistics were extracted from FSL and fed into SPSS for further analyses. MD 
and RD values were similarly processed and aligned to the FA skeleton. 
Statistical Analyses 
Data analyses were completed using the Statistical Package for the Social Sciences 
(SPSS), Version 24. Group differences on continuous demographic variables (i.e., age and 
education) were examined using an analysis of variance (ANOVA), while Pearson’s chi-square 
statistic was used on categorical data (i.e., gender and handedness). Independent samples t-test 
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and chi-square analyses were conducted to determine whether the patient groups differed in 
illness severity (PANSS symptom ratings, number of hospitalizations across the lifetime, 
employment and independent living status), class of antipsychotic medication, diagnosis 
(schizophrenia vs. schizoaffective/whether patients were on a mood stabilizer), and duration of 
illness (time since first psychiatric treatment for present disorder in years).  
Prior to parametric statistical testing of cognitive measures (i.e., premorbid and current 
estimates of intelligence, MCCB domains and composite, and adjunct social cognitive 
measures), Levene’s test for equality of variances was performed. If Levene’s test was violated, 
Hartley’s Fmax test (David, Hartley, & Pearson, 1954) was examined to ensure the variance ratio 
was below the critical value. An analysis of variance (ANOVA) or multivariate analysis of 
covariance (MANOVA) was carried out on the mean (raw, standard, or T-) scores for the 
cognitive measures to examine possible between group differences. However, covariance 
analyses (i.e., ANCOVA or MANCOVA) will be carried out instead if there were any significant 
demographic effects. Significant comparisons were further examined using Bonferroni post hoc 
analyses.  
Cortical parcellations were obtained for regions of interest (ROIs) using the Destrieux 
cortical atlas in Freesurfer (as outlined by Destrieux, Fischl, Dale, & Halgren, 2010; Fischl et al., 
2010), which provides bilateral hemispheric parcellation of gyral and sulcal structures. A priori 
ROIs were chosen for analysis in SPSS for each network (DMN, SN, CEN, and SBN; see 
Heinrichs et al., 2017; Kennedy & Adolphs, 2012; McMenamin, Langeslag, Sirbu, Padmala, & 
Pessoa, 2014; Menon & Uddin, 2010). Four network values were calculated for the cortical 
thickness data by averaging each networks’ ROIs. This approach was favourable because 
thickness changes among individuals with schizophrenia tend to be widespread rather than 
36 
 
localized and prevented the multiple comparisons problem (i.e., elevated false positives or type I 
error; Bennet, Wolford, & Miller, 2009; Lindquist & Mejia, 2015). Of note, ROIs common to 
multiple networks were included given that a brain region can belong to different networks 
(Najafi et al., 2016).  
Between-group comparisons and network analyses of cortical thickness and white matter 
tracts affiliated with key nodes from the DMN, CEN, SN, and SBN were performed. The data 
were first exported from Freesurfer and FSL software packages and fed into SPSS. Mean 
network thickness values were compared between groups. For DTI data, tract-based spatial 
statistical (TBSS) analyses were employed to determine fiber coherence and possible pathology. 
Specifically, FA, MD, and RD  measures were used to examine tract integrity between key hubs 
within and between each network: anterior insula to anterior cingulate cortex (salience network), 
posterior parietal cortex and dorsolateral prefrontal cortex (central executive network), posterior 
cingulate cortex and ventromedial prefrontal cortex (default mode network), and between the 
amygdala and superior temporal sulcus (social brain network).  
Levene’s test for inequality of variances was again conducted. Subsequently, a 
MANCOVA was performed to examine the effect of cognitive/diagnostic group status (i.e., 
cognitively normal range (CNR) patients and comparison controls, as well as below-normal 
range (BNR) patients and comparison controls) on cortical thickness and white matter integrity. 
Both age and education were included as covariates.  
Results 
Demographic Characteristics 
Group demographic and clinical characteristics are displayed in Table 1. Among the 
patient groups, below-normal range (BNR) patients were between 20 to 63 years of age and 
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completed 8 to 18 years of education while cognitively normal range (CNR) patients ranged 
from 25 to 50 years old with 12 to 16 years of education. For the control groups, BNR controls 
were between 30 and 60 years of age and had achieved between 7 to 12 years of education; CNR 
controls ranged between 19 to 66 years old and obtained 11 to 18 years of schooling. Bonferroni 
corrected post hoc comparisons revealed that below-normal range (BNR) patients were older and 
less educated than cognitively normal range (CNR) patients. Additionally, BNR controls were 
less educated than all other participant groups. Gender and right-handedness were relatively 
equal across groups. 
Table 1 
Demographic Characteristics for Cognitively Normal Range (CNR) and Below-Normal Range 
(BNR) Patients and Controls 
 
 
Variable 
1.CNR  
Patients  
(n=16) 
2.CNR 
Controls  
(n=36) 
3.BNR 
Patients  
(n = 48) 
4.BNR 
Controls  
(n =21) 
 
Statistic          
 
 
Age, years  
(M, SD) 
 
34.13 
(7.82) 
 
37.86 
(12.32) 
 
43.83 
(9.82) 
 
40.81 
(9.23) 
 
F3, 117 = 
4.47** 
 
 
Education, years  
(M, SD) 
  
 
14.44 
(1.41) 
 
13.33 
(1.60) 
 
12.45 
(2.23) 
 
10.43 
(1.66) 
 
F3, 117  = 
16.55*** 
 
Gender, males  
(n, %)  
10 
(63%) 
23 
(64%) 
31 
(65%) 
13 
(62%) 
χ 32 = 0.06  
       
Handedness, Right 
(n, %) 
14 
(88%) 
31 
(86%) 
37 
(77%) 
18 
(86%) 
χ 62 = 2.73  
WRAT-4 Reading 
SS (M, SD) 
100.38 
(7.54) 
101.36 
(8.57) 
89.43 
(10.50) 
83.90 
(9.07) 
F3, 115 = 
10.50*** 
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WASI-IQ Estimate, 
SS (M, SD) 
 
119.44 
(5.05) 
 
112.03 
(15.49) 
 
90.33  
(18.86) 
 
81.95 
(12.24) 
 
F3, 115 = 
19.30*** 
MCCB composite T 
(M, SD) 
47.06 
(5.14) 
50.47 
(6.70) 
24.88 
(9.48) 
27.00 
(10.01) 
F3, 115 = 
58.17*** 
 
 
Note. WRAT-4: Wide Range Achievement Test; WASI-IQ: Wechsler Abbreviated Scale of 
Intelligence-Intelligence Quotient (WASI-IQ), as measured by a combined score from the WASI 
Matrix Reasoning and Vocabulary subtests; MCCB: MATRICS Consensus Cognitive Battery; 
PANSS = Positive and Negative Syndrome Scale; * p .05, ** p .01, ***p .001 
 
Clinical Characteristics 
Clinical profiles for the two schizophrenia groups are presented in Table 2. Patient groups 
did not differ in psychiatric (i.e., positive, negative, general, or composite) symptomatology, 
ratio of patients with a schizoaffective vs. schizophrenia diagnosis or taking a mood stabilizer, 
age of illness onset, number of hospitalizations across the lifetime, employment and community 
living status, or class of antipsychotic medication. However, an Independent Samples t-test 
revealed that the two patient groups differed in their duration of illness (time since first 
psychiatric treatment) such that BNR patients had a longer illness duration than CNR patients.  
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Table 2 
 
Clinical Profiles for Cognitively Normal Range (CNR) and Below-Normal Range (BNR) Patients 
 
 
Variable 
 
 CNR Patients  
(n=16) 
 
3.BNR Patients  
(n = 48) 
 
Statistic 
PANSS Positive T (M, SD) 
 
PANSS Negative T (M, SD) 
 
PANSS General T (M, SD) 
 
PANSS Composite T (M, SD) 
 
Schizoaffective (%) 
 
   Mood Stabilizer (%) 
 
# of Hospitalizations (M, SD)1 
 
Age of Illness Onset, (M, SD)2 
 
Illness Duration, years (M, SD)2 
 
Unemployed (%)3 
 
Independent Living (%)4 
 
Medication (2nd generation; %)6 
39.00 (6.35) 
 
37.38 (7.97) 
 
38.00 (6.73) 
 
52.69 (6.67) 
 
44% 
 
20% 
 
3 (3.33) 
 
22.86 (5.78) 
 
11.26 (8.90) 
 
42% 
 
59% 
 
87% 
42.98 (8.13) 
 
39.04 (6.65) 
 
42.02 (7.93) 
 
53.29 (9.06) 
 
44% 
 
12% 
 
5.79 (8.48) 
 
24.82 (7.73) 
 
18.79 (9.95) 
 
38% 
 
57% 
 
66% 
t62= 1.78 
 
t62= .83 
 
t62= 1.82 
 
t62= .25 
 
χ 12 =.000 
 
χ 12 =.55 
 
t56= 1.27 
 
t58= .92 
 
t58= 2.66*** 
 
χ 32 =4.54 
 
χ 12 =.023 
 
χ 32 =4.46 
 
Note: MCCB = MATRICS Consensus Cognitive Battery; PANSS = Positive and Negative 
Syndrome Scale; * p =.05, ** p<.01, ***p .001; 1based on n=58 due to missing data for 6 
BNR patients; 2based on n=60 due to missing data for 4 BNR patients; 3based on n=59 due to 
missing data for 5 BNR patients; 4based on n=51 due to missing data for 11 BNR and 2 CNR 
patients; 5based on n=56 due to missing data for 7 BNR and 1 CNR patient. 
 
Neurocognitive Performance 
Each group’s performance on several cognitive measures is presented in Table 1 (above). 
Education and age were used as covariates given significant group differences. A two-way 
multivariate analysis of covariance (MANCOVA) revealed significant covariate effects for 
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education, while there was a trend towards significance for age (F (2, 114) = 6.50, p = .002 and 
F (2, 114) = 2.66, p = .074, respectively). There was a significant main effect of cognitive status 
(i.e., cognitively normal versus below-normal range) on intellectual functioning (F (2, 114) = 
26.25, p < .001) such that on both WASI IQ estimate and WRAT reading test participants within 
the cognitively normal range groups had higher scores than their below-normal range 
counterparts. However, psychiatric status (i.e., patient versus control) was non-significant (F (2, 
114) = 1.99, p = .141). Furthermore, the interaction between psychiatric and cognitive status was 
non-significant (F (2, 114) = 2.15, p = .121. Nonetheless, despite the non-significant interaction, 
a comparison between the four groups was considered important and meaningful (Wei, Carroll, 
Harden, & Wu, 2012), particularly in light of a priori predictions and the small and unequal 
sample sizes that suggest the study was underpowered to detect effects. 
Accordingly, a one-way MANCOVA was conducted to examine which specific group 
comparisons significantly differed. Performance patterns between groups were equivalent across 
WASI IQ estimate and MCCB composite score. Specifically, both CNR patients and controls 
had higher scores than BNR patients and controls. However, there were no differences found 
between cognitively normal patients and controls, or between below-normal patients and 
controls. Across reading skill (used to estimate premorbid ability), group differences were 
similar, although scores between the two patient groups approached significance (p = .056). 
Group differences on specialized cognitive measures commonly used in schizophrenia 
research (i.e., performance on MCCB domains) are depicted in Figure 2. The covariate age was 
significant, while education was non-significant. There were significant main effects for both 
psychiatric (patient versus control) and cognitive status (cognitively normal versus below-normal 
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range; (F (7, 109) = 4.71, p < .001 and F (7, 109) = 15.94, p <.001, respectively). However, there 
was no significant interaction (F (7, 109) = 1.16, p = .33.  
The effect of cognitive status on each domain specific MCCB scores was as follows: 
Speed of Processing (F (1, 115) = 25.93, p < .001), Attention/Vigilance (F (1, 115) = 59.16, p < 
.001), Working Memory (F (1, 115) = 44.66, p < .001), Verbal Learning (F (1, 115) = 56.51, p < 
.001), Visual Learning (F (1, 115) = 36.51, p < .001), Reasoning and Problem Solving (F (1, 115) = 
23.41, p < .001), and Social Cognition (F (1, 117) = 12.94, p < .001). The effect of psychiatric 
status was significant for the Processing Speed and Reasoning and Problem Solving domains 
only (F (1, 115) = 12.80, p = .001 and F (1, 115) = 13.50, p < .001, respectively). All other domains 
were non-significant: Attention/Vigilance (F (1, 115) = .28, p = .596), Working Memory (F (1, 115) 
= .21, p =.649), Verbal Learning (F (1, 115) = 1.76, p = .187), Visual Learning (F (1, 115) = 1.32, p 
= .252), and Social Cognition (F (1, 117) = .96, p = .330).  
Additionally, despite a non-significant interaction, a one-way MANCOVA was again 
conducted to examine specific group differences. Bonferroni adjusted post hoc analyses 
indicated that for the Processing Speed domain, cognitively normal range controls had faster 
reaction times than all other groups (i.e., cognitively normal patients, as well as below-normal 
range patients and controls). Cognitively normal range patients also had faster speed of 
processing than the below-normal range patients. With respect to the Attention/Vigilance 
domain, both cognitively normal range patients and controls obtained higher scores than their 
below-normal range counterparts. This pattern was also observed on the Working Memory, 
Verbal Learning, and Visual Learning domains of the MCCB. On the Reasoning and Problem 
Solving domain, cognitively normal range controls obtained higher scores than all other groups. 
Lastly, cognitively normal range controls and patients had higher scores than the below-normal 
range patients on the Social Cognition domain.   
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Figure 2. Performance profiles for patients and comparison controls across the Measurement 
and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus 
Cognitive Battery (MCCB) domains.  
 
Adjunct Specialized Cognitive Measures 
Levene’s test for equality of variances was violated for the Faux Pas stories. Examination 
of the variance ratio using Hartley’s Fmax test revealed ratios below the critical value of 3. On 
adjunct social cognitive measures, a two-way MANCOVA revealed a main effect of cognitive 
status (F (4, 110) = 9.58, p < .001) on all 3 cognitive measures (Faux Pas questions on the Faux Pas 
test: F (1, 113) = 21.00, p < .001, Control questions on the Faux Pas test: F (1, 113) = 4.00, p = 
.048; Reading the Mind in the Eyes: F (1, 113) = 18.79, p < .001, and the probabilistic reasoning 
(beads) task: F (1, 113) = 7.71, p = .006. Specifically, cognitively normal range participants 
outperformed cognitively below-normal range participants. Psychiatric status had a trend towards 
significance (F (4, 110) = 2.42, p = .053), but its effect on specific tasks were non-significant upon 
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further investigations. There was no interaction effect; age and education were non-significant 
covariates. 
A subsequent one-way MANCOVA conducted to examine specific group differences was 
significant (F (18, 306) = 4.77, p < .001); again, neither age nor education were significant 
covariates. Table 3 displays results from adjunct cognitive measures. Further investigations 
revealed significant effects for the Faux Pas questions on the Faux Pas test, Reading the Mind in 
the Eyes, and the probabilistic reasoning (beads) task. Bonferroni adjusted post hoc analyses 
indicated that cognitively normal range controls had higher scores than the below-normal range 
groups on Faux Pas stories suggestive of greater accuracy at detecting when a faux pas was 
committed. Cognitively normal range patients outperformed their below-normal range patient 
counterparts. An equivalent pattern was observed on the Reading the Mind in the Eyes test 
reflecting that the two cognitively normal range groups outperformed the below-normal range 
patients in identifying the emotions depicted in the eyes of subjects in a photograph. Cognitively 
normal range controls also outperformed below-normal range controls. On a probabilistic 
reasoning task, the below-normal range control group drew fewer beads prior to decision-making 
(suggestive of “jumping to conclusions”) when compared to the cognitively normal range 
groups. 
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Table 3 
 
Adjunct Cognitive Performance across Cognitively Normal Range (CNR) and Below-Normal 
Range (BNR) Patients and Controls 
 
Variable 1.CNR 
Patients 
(n=16) 
2.CNR 
Controls 
(n=36) 
3.BNR 
Patients  
(n=47) 
4.BNR 
Controls  
(n=20) 
F (3, 113) Bonferroni  
adjusted 
Comparisons 
Faux Pas test 
   FP questions 
 
49.31 
(5.43) 
 
50.69 
(4.68) 
 
35.56 
(13.18) 
 
41.00 
(11.64) 
 
14.64*** 
 
1>3; 2>3,4 
   CN questions 
19.81 
 (.40) 
19.83  
(.56) 
18.77 
(2.07) 
18.65 
(1.66) 
 
2.37  
 
1>3; 2>3,4 Reading the Mind 25.81 
(3.23) 
27.56 
(3.35) 
21.21 
(4.86) 
21.65 
(5.31) 
12.09*** 
Probabilistic Reasoning       
   Red/Blue Beads 10.44 
(2.42) 
9.11 
(4.21) 
7.51 
(4.99) 
4.60 
(3.24) 
2.93* 1,2>4 
* p < .05; ** p < .01; ***p < .001; FP: Faux Pas; CN: Control. 
Cortical Thickness 
With respect to whole-brain cortical thickness, the two-way MANCOVA revealed a 
significant effect of psychiatric status such that controls had greater cortical thickness than 
patients (F(4, 112) = 3.15, p = .017). However, there was no effect of cognitive status. 
Nonetheless, there was a significant interaction between psychiatric and cognitive status, (F(4, 
112) = 2.61, p = .039), though further investigations were non-significant. While age was a 
significant covariate (F(4, 112) = 16.06, p < .001), education was non-significant. Similarly, 
network analyses revealed significant group differences between patients and controls (F(4, 112) 
= 4.81, p = .001) for the DMN, SN, and SBN, but not the CEN. For these three networks, 
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controls had greater cortical thickness than patients. There was no effect of cognitive status on 
network cortical thickness, and the interaction was similarly non-significant. 
A one-way MANCOVA (see Table 4) was conducted as a follow-up to examine specific 
group differences and revealed that CNR controls had greater whole-brain thickness than BNR 
patients only. As for network analyses, univariate F ratios were significant for the DMN, SN, 
and SBN, but not the CEN (see Table 5). Pairwise comparisons revealed that CNR controls had 
greater cortical thickness than both patient subgroups in the DMN and SN, but SBN pairwise 
comparisons did not survive Bonferroni corrections. For the SBN, there was a trend for the 
comparison between CNR controls and BNR patients, with the former having greater cortical 
thickness (p = 0.071). The covariate age was significant (F(4, 112)  = 13.88, p < .001, partial η2 
= .33), while education was not (F(4, 112) = .86, p = .490, partial η2 = .03). 
Tract Based Spatial Statistics: Group by Tract Analysis 
With respect to average whole-brain fractional anisotropy (FA), mean diffusivity (MD), 
and radial diffusivity (RD), there was no effect of cognitive status, but there was a significant 
main effect of psychiatric status on average RD and FA only (F(4, 112) = 3.15, p = .017, partial 
η2 = .10) such that controls had greater FA and lower RD than patients. There was a significant 
interaction (F(4, 112) = 2.61, p = .039), though further analyses showed significance for average 
FA only (F(1, 115) = 5.08, p = .026), with controls having greater FA than patients. The 
covariate age was significant while education was not (F(4, 112) = 16. 06, p < .001 and F(4, 112) 
= .40, p = .809, respectively).  
Additional analyses were performed by conducting a one-way MANCOVA to examine 
group differences in light of a priori predictions, current significant interaction, and consideration 
of the study’s small and unequal sample sizes. Using Bonferroni adjusted pairwise comparisons, 
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cognitively normal range (CNR) controls had higher average FA than both schizophrenia patient 
groups, and lower RD values than the same, after controlling for age and education (see Table 4).  
Table 4 
Average Whole-Brain Fractional Anisotropy, Mean Diffusivity, Radial Diffusivity, and Cortical 
Thickness in Cognitively Normal Range (CNR) and Below-Normal Range (BNR) Patients and 
Controls 
 
Variable 1.CNR 
Patients 
(n=16) 
2.CNR 
Controls 
(n=36) 
3.BNR 
Patients  
(n=48) 
4.BNR 
Controls  
(n=21) 
F (3, 115) Bonferroni 
Adjusted 
Comparisons 
FA (M, SD) .48 (.02) .50 (.03) .47 (.03) .47 (.03) 4.85** 2>1,3 
MD (M, SD) .80x10-3 
(.03x10-3) 
.80x10-3 
(.02x10-3) 
.80x10-3 
(.02x10-3) 
.78x10-3 
(.04x10-3) 
.92 NA 
RD (M, SD) 1.49x10-3 
(.12x10-3) 
1.39x10-3 
(.14x10-3) 
1.52x10-3 
(.14x10-3) 
1.46x10-3 
(.16x10-3) 
5.16** 2<1,3 
CT (M, SD) 2.49 (.09) 2.55 (.11) 2.44 (.11) 2.50 (.13) 4.53** 2>3 
* p < .05; ** p < .01; ***p < .001. The means and standard deviations are displayed for 
diffusion tensor imaging measures (including fractional anisotropy (FA), mean diffusivity 
(MD), and radial diffusivity (RD)), and cortical thickness (CT). 
 
Examining individual tracts, there was a main effect of psychiatric status (F(15, 101) = 
1.97, p = .025). Further analyses revealed significant group differences for the FA of the genu of 
the corpus callosum (GCC; F(1, 115) = 4.12, p = .045 and uncinate (UNC; F(1, 115) = 5.40, p = 
.022); UNC medial diffusivity (F(1, 115) = 4.63, p = .034), and for RD of the GCC and sagittal 
stratum (SS; F(1, 115) = 5.02, p = .027 and F(1, 115) = 10.50, p = .002, respectively). Of note, 
the p value for the superior longitudinal fasciculus (SLF) was marginally significant (F(1, 115) = 
3.77, p = .055). The results suggest that controls have greater white matter integrity than patients. 
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The main effect of cognitive status was non-significant. Additionally, the interaction between the 
two factors approached significance (F15, 101 = 1.64, p = .075), although further examination 
revealed significance for the GCC radial diffusivity alone (F(1, 115) = 4.95, p = .028). The 
covariate age was significant (F(15, 101) = 3.81, p < .001), while education was not.  
A one-way MANCOVA was again conducted to examine specific group differences. The 
analyses revealed significant group differences for RD, while FA and MD were non-significant 
(see Table 5). The genu of the corpus callosum (GCC), superior longitudinal fasciculus (SLF), 
and the sagittal stratum (SS; which includes the inferior longitudinal fasciculus and inferior 
fronto-occipital fasciculus) were the only tracts with significant F ratios. For the GCC, CNR 
controls had lower values than both patient groups. With respect to the SLF, CNR controls had 
lower RD values than below-normal range (BNR) patients only, while for the SS CNR controls 
had lower RD values than CNR patients. The covariate age was significant (F(5, 111) = 5.07, p < 
.001, partial η2 = .19), and education was non-significant (F(5, 111) = 1.84, p = .111, partial η2 = 
.08).  
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Table 5 
Fractional Anisotropy (mm), Mean Diffusivity, and Radial Diffusivity of Key Tracts in Cognitively Normal Range (CNR) and Below-
Normal Range (BNR) Patients and Controls 
 
Variable 1.CNR 
Patients 
(n=16) 
2.CNR 
Controls  
(n=36) 
3.BNR 
Patients  
(n=48) 
4.BNR 
Controls  
(n=21) 
F (3, 115) Bonferroni 
Adjusted 
Comparisons 
Fractional anisotropy  
 
   
1.42 
 
CGC (M, SD) .62 (.04) .64 (.05) .62 (.04) .63 (.05) 
  
GCC (M, SD) .69 (.03) .70 (.03) .69 (.03) .70 (.04)   
SLF (M, SD) .53 (.03) .53 (.03) .52 (.02) .53 (.03)   
SS (M, SD) .58 (.04) .58 (.03) .57 (.03) .58 (.04)   
        UNC (M, SD) .60 (.04) .62 (.04) .62 (.05) .63 (.06)   
Mean diffusivity 
 
   1.33 
 
CGC (M, SD) .77x10-3 
(.03x10-3) 
.79x10-3 
(.03x10-3) 
.78x10-3 
(.03x10-3) 
.77x10-3 
(.05x10-3) 
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GCC (M, SD) .84x10-3 
(.06x10-3) 
.84x10-3 
(.04x10-3) 
.84x10-3 
(.05x10-3) 
.80x10-3 
(.07x10-3) 
 
 
SLF (M, SD) .75x10-3 
(.04x10-3) 
.76x10-3 
(.03x10-3) 
.76x10-3 
(.03x10-3) 
.74x10-3 
(.04x10-3) 
 
 
SS (M, SD) .83x10-3 
(.05x10-3) 
.83x10-3 
(.03x10-3) 
.83x10-3 
(.03x10-3) 
.81x10-3 
(.05x10-3) 
 
 
        UNC (M, SD) .87x10-3 
(.05x10-3) 
.85x10-3 
(.06x10-3) 
.87x10-3 
(.06x10-3) 
.84x10-3 
(.07x10-3) 
 
 
Radial diffusivity 
 
   2.00* 
 
CGC (M, SD) .96x10-3 
(.09x10-3) 
.90x10-3 
(.08x10-3) 
.96x10-3 
(.10x10-3) 
.95x10-3 
(.11x10-3) 
2.27 
 
GCC (M, SD) 2.15x10-3 
(.31x10-3) 
1.85x10-3 
(.40x10-3) 
2.12x10-3 
(.32x10-3) 
2.02x10-3 
(.25x10-3) 
5.61** 2<1,3 
SLF (M, SD) 1.03x10-3 .95x10-3 1.05x10-3 1.03x10-3 3.48* 2<3 
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(.13x10-3) (.12x10-3) (.13x10-3) (.14x10-3) 
SS (M, SD) 1.47x10-3 
(.30x10-3) 
1.29x10-3 
(.26x10-3) 
1.49x10-3 
(.29x10-3) 
1.36x10-3 
(.18x10-3) 
4.09** 2<1 
        UNC (M, SD) 2.87x10-3 
(.13x10-3) 
2.85x10-3 
(.24x10-3) 
2.90x10-3 
(.17x10-3) 
2.84x10-3 
(.27x10-3) 
.73 
 
Cortical Thickness Networks     3.00**  
Central Executive (M, SD) 2.56 (.10) 2.58 (.15) 2.51 (.13) 2.56 (.16) .99 
 
Default Mode (M, SD) 2.75 (.13) 2.85 (.13) 2.70 (.14) 2.79 (.15) 7.80*** 2>1,3 
Salience (M, SD) 2.74 (.12) 2.82 (.14) 2.69 (.14) 2.76 (.15) 4.84** 2>1,3 
Social Brain (M, SD) 2.67 (.12) 2.74 (.12) 2.65 (.12) 2.70 (.15) 3.09* non-sig. 
* p < .05; ** p < .01; *** p < .001; CGC: cingulum (cingulate gyrus); GCC: genu of the corpus callosum; SLF: superior longitudinal 
fasciculus; SS: sagittal stratum (includes the inferior longitudinal fasciculus and inferior fronto-occipital fasciculus); UF: uncinate 
fasciculus; Mean and radial diffusivity relatively small values and rounded to three decimal places. 
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Summary of Findings 
Table 6  
A Summary of the Study’s Predictions, Neuroimaging Results and whether the Hypotheses were Supported, as well as Supportive 
Evidence from the Cognitive Data 
 
Variables Hypothesis Neuroimaging Results Hypothesis 
supported 
Support from the  
Cognitive Data 
Cortical 
Thickness 
Both patient groups will have 
comparable cortical thinning patterns 
in the salience network relative to 
cognitively normal controls 
Cognitively normal range (CNR) 
controls had greater thickness than 
both patient groups; no difference 
between control groups 
 
 
 
 Both patient groups will have 
comparable cortical thinning patterns 
in the default mode network relative 
to cognitively normal controls 
 
CNR controls had greater thickness 
than both patient groups; no 
difference between control groups. 
 
 
 Both patient groups will have 
comparable cortical thinning patterns 
in the social brain network relative to 
cognitively normal controls 
CNR controls had greater cortical 
thickness than below-normal range 
(BNR) patients: trend towards 
significance 
 
On social cognitive 
measures, CNR controls 
outperformed BNR 
patients on 3 of 4 tasks; 
CNR patients and 
controls did not differ 
 
White 
Matter 
Integrity 
Both patient groups will show 
dysconnectivity in the genu of the 
corpus callosum 
Both patient groups had reduced 
white matter integrity than 
cognitively normal range controls 
 
 
 
 Both patient groups will show 
dysconnectivity in the uncinate 
fasciculus 
Not significant 
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 Both patient groups will show 
dysconnectivity in the cingulum 
Not significant 
 
 
 Both patient groups will show 
dysconnectivity in the sagittal stratum 
 
Cognitively normal range controls 
had greater white matter integrity 
than cognitively normal range 
patients 
 
 
On most social 
cognitive measures, 
CNR controls 
outperformed BNR 
groups; CNR patients 
outperformed BNR 
patients 
 
 Cognitively normal range patients and 
controls will have comparable white 
matter integrity in the superior 
longitudinal fasciculus (SLF); 
group differences were expected 
between cognitively normal and 
below-normal range participants 
Cognitively normal range patients 
and controls did not differ; 
Cognitively normal range controls 
and below-normal range patients 
differed;  
No other group differences were 
observed 
 
 
 
 
CNR groups outscored 
BNR groups on 
processing speed, 
attention, and working 
memory 
 Cognitively normal range controls will 
have greater whole-brain connectivity 
than both patient groups 
Cognitively normal range controls 
had greater whole-brain 
connectivity (increased fractional 
anisotropy and decreased radial 
diffusivity) than both patient 
groups 
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Discussion 
 The goal of the current study was to investigate whether psychotic illness and cognitive 
impairment represent independent disease processes by comparing cortical structure and network 
connectivity across cognitively normal and impaired patients and controls. Specifically, we 
investigated whether aberrations in brain networks’ cortical thickness and/or structural 
connectivity are associated with cognitive impairment and/or the severity of psychotic 
psychopathology. Overall, we found neuroimaging evidence that cognitive impairment and 
psychotic illness are separable disease processes. The findings suggest that the inclusion of both 
cognitively normal range patients and below-normal range controls in schizophrenia research is 
beneficial to help identify the separable effects of cognition and psychosis on behavioural and 
neuroimaging data. 
Hypothesis 1 
Cognitively normal and below-normal range patients will have comparable severity of 
psychopathological symptoms. 
The data revealed that cognitively normal and below-normal range patients were 
indistinguishable in the severity of psychiatric symptoms and illness impact (i.e., positive, 
negative, and general symptoms; diagnosis of schizoaffective vs. schizophrenia, antipsychotic 
and mood stabilizer medications, number of hospitalizations, as well as employment and 
community living status). However, on average, below-normal range (BNR) patients had a 
longer duration of illness than cognitively normal range patients. This finding is perhaps 
consistent with the BNR patients’ older age. The comparable symptom severity levels and illness 
impact across patient groups suggest that differences found on neurocognitive measures or 
neurobiological findings are largely influenced by underlying processes contributing to their 
different cognitive profiles or at least that the differences found are not driven by the severity of 
psychotic symptoms.  
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Hypothesis 2 
On intellectual functioning, standard consensus (except for processing speed), and adjunct 
specialized cognitive measures, cognitively normal range groups will have inappreciable 
differences in performance (and likewise the below average range groups) and outperform their 
below-average range counterparts. 
 As noted earlier, BNR patients were less educated and older than the cognitively normal 
range patients, and BNR controls were less educated than all other comparison groups. Thus, age 
and education were used as covariates. In general, the cognitive data suggest that cognitive 
impairment and psychosis are largely independent, consistent with the extant literature (de 
Gracia Dominguez et al., 2009; Heinrichs et al., 2015). Specifically, performance profiles on 
standard consensus cognitive measures were such that the cognitively normal range participant 
groups achieved higher neurocognitive performance than individuals belonging to the below-
average range cognitive groups. Additionally, these findings on standard cognitive measures 
were complemented by the lack of within group differences. This performance pattern was also 
observed on 4 of 7 domains of the MATRICS Consensus Cognitive Battery (MCCB), including 
the Attention/Vigilance, Working Memory, Verbal Learning, and Visual Learning indices. The 
three exceptions include the domains of Processing Speed, Reasoning and Problem Solving, and 
Social Cognition. On the Processing Speed domain, cognitively normal range controls 
outperformed all other groups, including cognitively normal range patients. Additionally, among 
the two patient groups, those within the cognitively normal range obtained higher performance 
than the below-normal range group. There were no differences found between the below-normal 
range groups. For Reasoning and Problem Solving, cognitively normal range controls again 
achieved higher scores than all other participant groups. Lastly, performance within ability level 
was indistinguishable on the Social Cognition index; however, there was a significant difference 
between ability level such that cognitively normal range patients and controls obtained higher 
scores than below-normal range patients. 
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 Importantly, given that MCCB domain scores are highly correlated with the MCCB 
composite that was used to create the groups, these findings are not surprising. Thus, the 
inclusion of independent cognitive measures was warranted to corroborate findings and/or 
provide additional information. First, performance patterns on other measures of intellectual 
functioning (i.e., estimate of premorbid intelligence and IQ estimate) revealed no significant 
difference between patients and controls within the same cognitive ability level, though there 
was a significant difference between ability levels. Thus, that cognitively normal patients and 
controls had higher estimates of premorbid intelligence and IQ than below-normal range patients 
and controls provide support for the use of the MCCB composite normality criterion. Thus, 
within a given ability level, these groups were indistinguishable on premorbid ability and IQ 
estimate, consistent with our typology.  
 Taken together, the data consistently revealed that processing speed and 
reasoning/problem-solving are sensitive to both psychosis and cognitive impairment. That is, 
even when the effects of age and education were controlled, both patient groups and below-
normal range controls significantly underperformed cognitive normal range comparison controls. 
Processing speed is considered to be sensitive to schizophrenia illness with the relatively largest 
effect size of all cognitive domains found impaired (Schaefer, Giangrande, Weinberger, & 
Dickinson, 2013). Reduced speed of processing has previously been found among cognitively 
normal range individuals with schizophrenia (Heinrichs et al., 2015; Holthausen et al., 2002; 
Vaskinn, Ueland, Melle, Agartz, Andreassen, & Sundet, 2014). Processing speed is also highly 
correlated with overall cognitive functioning, particularly higher-order functioning, and it is a 
good indicator of cognitive decline (Kail & Salthouse, 1994; Chopra, Shaw, Shaw, Sachdev, 
Anstey, & Cherbuin, 2018). Our study’s findings of diminished processing speed and reasoning 
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skills among below average range controls are consistent with the evidence that these abilities 
are linked to overall cognition. 
 Meta-analytic studies and systematic reviews suggest that both processing speed and 
reasoning abilities, which are also linked to general cognition, are among the cognitive domains 
that correlate with functional outcome (Fett et al., 2011; Green, 1996; Green et al., 2004). 
Patients within this study had high rates of unemployment, at approximately 40%. Although 
employment rates were not assessed for the below-normal range control group, many were 
recruited from employment services and individuals with low education within the community 
typically have higher rates of unemployment than community dwellers with higher levels of 
education (Statistics Canada). Indeed, in 2011 (around the time of this research), employment 
rates ranged from 4.4% among individuals with “above Bachelor’s degree” to 13.4% in those 
with up to 8 years of education. The unemployment rate among community dwellers with some 
high school education, like our below-normal range control group, was 10.5%. According to the 
Ontario Labour Force Survey (December 2012), the unemployment rate within the general 
population was approximately 7.9% in 2011, with the overall Canadian rates at around 7% 
annually (with the exception of more recent rates at a low of 5.5% (Statistics Canada, 2012, 
2019). Comparatively, both cognitive ability and schizophrenia illness impact overall functioning 
within the community, but schizophrenia illness understandably has a more profound impact on 
functioning.  
 It is known that social cognition, which is typically impaired in schizophrenia, is an 
additional strong predictor of functional outcome (as measured by occupational achievement, 
interpersonal relationships, and ability to manage instrumental activities of daily living) as well 
as illness recovery (Dodell-Feder, Tully, & Hooker, 2015; Green, Lee, & Ochsner, 2013). 
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Individuals with good social cognitive skills, as measured on the Social Cognition index of the 
MCCB, readily identify, differentiate, understand, and manage emotions or emotional reactions 
(Savla, Vella, Armstrong, Penn, & Twamley, 2012). From the current findings, it appears that 
social cognitive deficit is present only in cognitively compromised individuals with 
schizophrenia (and not in either cognitively normal range patients or below-normal range 
controls). This finding would suggest a comorbid effect of both cognitive and psychotic illness 
influencing social cognitive processing. However, adjunct measures of social cognition were also 
included to corroborate findings from the MCCB. 
 The chosen adjunct measures of social cognition and probabilistic reasoning were 
included in light of evidence supporting their sensitivity to psychotic thinking (e.g., delusions). 
Overall, the outcome of these measures was congruent with findings that reduced overall 
cognitive abilities underly poor social cognitive and reasoning skills and not psychosis alone. On 
these specialized psychopathology-sensitive cognitive measures, patients and controls within the 
cognitively normal range group were again indistinguishable, and they typically outperformed 
the below-normal range patients and/or controls. Specifically, on tests of Theory-of-Mind or 
social reasoning about the mental states of a person, the below-normal range patients and 
controls had more significant difficulty than control participants in the normal range group when 
trying to make inferences about others’ mental states from facial expressions or identifying 
whether a faux pas committed in a social interaction was intentional. Below-normal range 
participant groups were indistinguishable on these measures. Thus, these findings suggest that 
low general cognitive ability is sufficient for impairment in social cognition, particularly theory 
of mind.  
 Additionally, it was the below-normal range controls, but not patients, that were more 
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likely to “jump to conclusions” on a probabilistic reasoning task. This finding was surprising as 
it invalidates the Jumping to Conclusions (JTC) test as being sensitive to psychotic (particularly, 
delusional) thinking (So et al., 2016; Ross et al., 2015). Some research evidence suggests, 
however, that the link between delusional thinking and “jumping to conclusions” disappears 
once general cognitive functioning is controlled (Bentall et al., 2009; Ross et al., 2015). Another 
study found a small effect of a reduction in hasty decision-making once cognitive remediation 
training was provided (which includes training on attention, working memory, and executive 
functions; Andreou, Schneider, Balzan, Luedecke, Roesch-Ely, Mortiz, 2015). This finding 
provides support for a link between hasty decision-making with minimal information and 
reduced working memory and executive functions (Andreou et al., 2015; Garety et al., 2013, 
2014).  
 Alternatively, it may be that the beads task fails to measure true faulty decision-making 
due to methodological limitations, reduced motivation/effort, or possible poor comprehension of 
instructions (Ross et al., 2015). It may also be that the task is only effective in detecting the 
jumping to conclusions bias when delusional thinking is extreme in clinical samples versus 
nonclinical comparison samples or on account of a possible nonlinear relationship between the 
JTC bias and severity of delusional thinking (So & Kwok, 2015). Nonetheless, our findings fit 
within the context of this literature linking the JTC bias to cognitive impairment rather than 
delusions. The data also underscore the utility in investigating both cognitive normality and 
impairment among patients and comparison controls in schizophrenia research. Taken together, 
the data revealed that cognition and psychosis are independent disease processes as well as 
comorbidities. 
Hypothesis 3 
Cortical thinning patterns will be largely comparable between patient groups reflecting a 
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common underlying psychopathology, with notable thinning in SN, DMN, and SBN when 
compared to cognitively normal controls. 
 Consistent with our predictions, cortical thickness network analyses revealed significant 
group differences in the salience, default mode, and social brain networks but not the central 
executive network. However, only the salience and default mode networks remained significant 
following Bonferroni post hoc corrections. Consistent with findings from Heinrichs’ and 
colleagues (2017) using some of the same overlapping participants, cognitively normal controls 
had greater cortical thickness in the SN and DMN networks than both patient groups with no 
differences between the patient groups. These findings suggest that cortical thickness is 
indicative of shared underlying psychotic psychopathology unrelated to cognitive status. Of note, 
cortical thickness among the control groups were also indistinguishable, which provides further 
support that cognitive performance and cortical thickness are independent.  
 With respect to the SBN, the comparison between cognitively normal range controls and 
below-normal range patients approached significance, with the patient group exhibiting 
significant cortical thinning in these brain regions. If this finding can be replicated with a larger 
sample size, it would underscore a point of divergence between the patient groups. That is, it 
may be that at least in these brain regions patients with comorbid cognitive impairment and 
psychosis fair worse than the typical comparison controls, while patients with normal thinning in 
this area have preserved cognitive functioning. Thus, this finding would suggest that cortical 
thinning in the SBN may contribute to comorbid psychotic psychopathology and cognitive 
impairment.  
Of note, this finding is consistent with the results from performance on the social 
cognitive measures. As a reminder, cognitively normal range controls outperformed below-
normal range patients; however, there were no significant differences between cognitively 
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normal patients and controls. Additionally, the behavioural data was more sensitive in picking up 
significant group differences between cognitively normal and below-normal range controls as 
well as between the two patient groups. The sensitivity of neurocognitive data to group 
differences has been previously illustrated (Heinrichs 2005). Here, the data suggest that perhaps 
group differences on social cognitive measures index cognitive ability and not psychopathology. 
Taken together, the data point to psychotic psychopathology and cognitive impairment as 
dissociable disease processes; the results are further suggestive of an influence of cortical 
thinning in the SBN on social cognitive impairment in below-normal range patients. 
Nonetheless, cortical thickness in the SN and DMN, in particular, indexes a shared disease 
process. 
Hypothesis 4 
We hypothesized that both patient groups will have compromised white matter integrity across 
all four tracts given their associations to cognitive functioning and psychotic symptoms (i.e., 
genu of the corpus callosum, uncinate fasciculus, cingulum, and sagittal stratum), when 
compared with cognitively normal range controls. We predicted that below-normal range 
patients will have greater reductions than cognitively normal range patients (relative to 
cognitively normal range controls) given the presence of both disease processes among this 
group (i.e., cognitive impairment and psychotic symptoms). We hypothesized that the integrity of 
the superior longitudinal fasciculus may differentiate the patient groups given this areas role in 
cognition. It was anticipated that there will be no difference between the cognitively normal 
range patients and controls. However, significant group differences were expected between the 
cognitively normal range groups and their below-normal range counterparts. Whole-brain white 
matter integrity will be lower among patients than cognitively normal range controls, which has 
been consistently shown (Kelly et al., 2018).  
 First, cognitively normal range controls had greater average whole-brain fractional 
anisotropy (FA) and lower radial diffusivity (RD) than both patient groups following corrections 
for age and years of education. These results are consistent with the extant literature, with a 
recent meta-analysis study by Kelly and colleagues (2018) showing the largest effect size mean 
difference between schizophrenia participants and controls in average FA. Of note, decreased FA 
usually results from either increased RD (indicative of myelin damage) or reduced axial 
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diffusivity (suggestive of axonal injury, but not measured in the current study) (Alexander et al., 
2007). Our findings of the microstructural white matter abnormalities observed were reflective of 
myelin disintegration in light of the difference in radial diffusivity, which fit well with previous 
findings (Kelly et al., 2018). 
 With respect to specific tracts, only average RD (and not FA or mean diffusivity) was 
significant for 3 of the five tracts (i.e., the genu of the corpus callosum, superior longitudinal 
fasciculus, and sagittal stratum), after controlling for age and years of education. Of course, a 
failure to detect group differences in average FA may be due to low sample size combined with a 
possible increased sensitivity of RD in detecting group differences in myelination of these 
particular tracts. It is possible to detect modest changes in myelination as measured by RD with 
intact anisotropy (Alba-Ferrara & de Erausquin, 2013). Cognitively normal range controls were 
observed to have reduced RD suggestive of greater myelin integrity in the genu of the corpus 
callosum when compared to both patient groups. Cognitively normal range controls also had 
reduced RD in the superior longitudinal fasciculus compared to the below-normal range patients 
only as well as reduced average RD in the sagittal stratum in comparison to cognitively normal 
range patients. 
 As predicted, both cognitively normal and below-normal range patients had reduced 
white matter integrity of the genu of the corpus callosum (GCC) when compared to cognitively 
normal range controls. These results are in keeping with previous findings that suggest that the 
GCC is involved in psychotic symptomatology as well as prefrontal cortex interhemispheric 
communication important for cognition (Di Biase et al., 2017; Kelly et al., 2018). Thus, the GCC 
indexes both cognitive status and the psychotic disease process, and evidence of its possible 
demyelination in patients supports the dysconnectivity hypothesis (Brandl et al., 2019; 
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Pettersson-Yeo et al., 2011). The indistinguishable GCC structural pattern between the patient 
groups highlight shared underlying neural mechanisms of the disease that give rise to psychosis 
and/or cognitive impairment. Of course, we cannot rule out the possibility that differences 
between patient groups were undetected because of the small sample size and/or controlling the 
effect of education. 
Despite the sagittal stratum’s role in both social cognitive processes (e.g., facial 
recognition and emotional perception) and positive symptoms (Jou et al., 2011; Oestreich, 
McCarthy-Jones, & Whitford, 2016; Seitz et al., 2016), only comparisons between the 
cognitively normal range groups differed. The behavioural data from this study do not 
corroborate these findings. Indeed, both cognitively normal range patients and controls were 
indistinguishable on social cognitive measures. The present data suggest that perhaps increased 
RD in cognitively normal range patients may index more efficient connectivity. Previous 
research evidence has shown that greater cortical thickness does not always mean better 
functioning, while cortical thinning can index cortical efficiency (Meyer, Liem, Hirsiger, Jäncke, 
& Hänggi, 2014). Similarly, higher FA has been linked to cognitive deficits in some populations 
(Alba-Ferrara & de Erausquin, 2013; Hoeft et al., 2007). Perhaps the opposite is also true in that 
reduced FA (due to increased RD) may indicate greater efficiency in thinking among cognitively 
normal range patients.  
 Lastly, it was hypothesized that the superior longitudinal fasciculus (SLF) would 
differentiate the patient groups in light of its association with cognitive control (e.g., working 
memory) and processing speed (Schaeffer et al., 2015; Turken et al., 2008). The cognitively 
normal range control group differed from the below-normal range patient group only, while no 
significant differences were found between the cognitively normal range groups, below-normal 
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range groups, or the two patient groups. Nonetheless, the significant group difference here is an 
important finding as it replicates well-established evidence between the usual comparison groups 
in schizophrenia research for this tract (Kelly et al., 2018; Schaeffer et al., 2015). The data 
suggest that the more typical cognitively compromised patients have greater myelin damage in 
this tract relative to cognitively normal controls. Indeed, cognitive control deficits have been 
linked to dorsolateral prefrontal cortex aberrations given its connections (e.g., via the SLF) to a 
wide range of brain areas, which include the parietal cortex, thalamus and striatum (Barch & 
Ceaser, 2012). 
 Of note, our neurocognitive data similarly showed cognitively normal range controls 
outperformed below average patients on measures of processing speed and executive functions 
(i.e., reasoning and problem-solving). However, the behavioural data were more sensitive in 
picking up differences between cognitively normal patients and the cognitively below-normal 
range patients and/or controls on measures. It has been previously argued that structural imaging 
studies tend to be less sensitive in detecting disease effects relative to neurocognitive 
performance data in schizophrenia research (Heinrichs, 2005). Additionally, structural imaging 
data can be variable from study to study with relatively modest effect sizes even with large 
sample sizes (Kelly et al., 2018). Our results support the findings that neurocognitive 
performance is sensitive in distinguishing the impact of psychotic illness from cognitive 
impairment.  
In sum, the current findings suggest that cortical dysconnectivity in schizophrenia spans 
across networks and accounts for the neurocognitive dysfunction, psychotic features, or presence 
of both in keeping with the extant literature (Pettersson-Yeo et al., 2011). In the current study, 
the results suggest that aberrant GCC white matter integrity may underlie the psychopathology of 
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schizophrenia illness given the shared disruptions in both cognitively normal and below-normal 
range patient groups. On the other hand, demyelination of the SLF appears to be associated with 
comorbid psychosis and cognitive impairment, while increased RD of the SS may index more 
efficient connectivity in cognitively normal range patients. Similarities found between 
cognitively normal range and below-normal range patients highlight shared underlying neural 
mechanisms of the disease, while dissimilarities pinpoint processes possibly linked specifically 
to cognitive status and/or comorbidity of psychosis and cognitive impairment. Thus, our findings 
show that white matter disintegration partially dissociates cognitive impairment and psychosis in 
schizophrenia illness. 
Limitations 
 A major limitation of the present study was the relatively small sample size, particularly 
in the cognitively normal range group. Indeed, we may have been underpowered to detect 
significant group differences between the patients on both cognitive performance (e.g., MCCB 
composite score) and imaging measures (i.e., cortical thickness, fractional anisotropy, medial 
diffusivity, and radial diffusivity) because of sample size, particularly after employing multiple 
comparison procedures. Studies have failed to find significant differences in fractional 
anisotropy when sample sizes are small (Wheeler & Voineskos, 2014). Nonetheless, cognitively 
normal range individuals with schizophrenia represent 15-25% of the  patient population 
(Ammari, Heinrichs, & Miles, 2010; Heinrichs et al. 2008; Muharib, Heinrichs, Miles, Pinnock, 
McDermid Vaz, & Ammari, 2014; Palmer et al., 1997), and our study’s sample had a rate of 
25%, which is at the upper end. Nevertheless, the promising current findings combined with the 
potential scientific value inherent in cognitively normal schizophrenia samples support the 
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importance for continued attempts to recruit this minority clinical population despite its 
challenges. 
 Although this study uses a convenience sample where only structural (and not functional) 
data were collected, structural integrity is closely related to functional connectivity 
(Hermundstad et al., 2013). Recent imaging data suggests that at least in some brain regions, 
functional dysconnectivity and diminished gray matter volume overlap and have a bi-directional 
relationship (Brandl et al., 2019). Of course, possible inconsistencies in our findings relative to 
the literature could be due to poor manual tracing for regions of interest or poor fractional 
anisotropy registration (Palaniyappan & Liddle, 2012). However, the imaging data preprocessing 
was carried out by imaging experts who underwent several inspections of the scans for quality 
control. The white matter results replicated previous data. Previous investigations have 
questioned the value in examining tract-based differences given the variability between studies 
as well as the fact that stable group differences are likely based in network approaches across the 
brain (Wheeler & Voineskos, 2014). 
 For the cortical thickness data, there were no group differences found for either the 
central executive or the social brain network, though there was a trend for the latter between the 
cognitively normal range controls relative to typically cognitively compromised patients. Despite 
both networks importance in at least distinguishing more broadly between schizophrenia patients 
and controls (Anticevic et al., 2012; Hu et al., 2017; Menon, 2011; Nekovarova, Fajnerova, 
Horacek, & Spaniel, 2014), the failure to detect differences in this study may be due to the 
inclusion of the same regions of interest in two or more network thickness values. Thus, these 
values were neither independent, nor differentially weighted and thus their true contributions 
within a network was not accounted for. The anterior insular cortex, for example, is known for 
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its role in cognitive control and emotional awareness (Uddin, Nomi, Hebert-Seropian, Ghaziri, & 
Boucher, 2017); it is included in the salience, central executive, and social brain networks. Taken 
together, the present study provides some support for the importance of different network 
cortical thinning patterns, but these findings need to be corroborated.   
 Another possibility is that if schizophrenia illness is indeed a syndrome, it is possible that 
the way patients were grouped in our study precluded finding significant structural differences as 
within group heterogeneity dilutes effects and reduces statistical power (Brandl et al., 2019). 
There were also some group differences on demographic and clinical characteristics; for 
example, below-normal range patients were older and less educated than cognitive normal range 
patients with longer duration of illness. However, given that schizophrenia is characterized by 
cognitive impairment and a possible neurodegenerative process (such that the disease may cause 
accelerated aging in some patients) controlling for education and age can be inappropriate and 
possibly dampen effects (Czepielewski et al, 2017; di Biase et al., 2017; Nguyen, Eyler, & Jeste, 
2017). Thus, that significant findings remained after using age and education as covariates 
suggest relatively robust differences. Additionally, in light of findings of social cognitive deficits 
among comparison controls that fall in the below average range, there may have been 
undiagnosed psychiatric problems. However, controls were screened to rule out any 
neurological, endocrine, psychiatric, or substance use disorders, though a non-patient edition of 
the structured clinical interview for DSM-IV (First et al., 1996) was not used. 
Conclusions 
 This study aimed to examine whether psychotic illness and cognitive impairment were 
dissociable illness processes as indexed by cortical network abnormalities and/or structural 
dysconnectivity. The presence of a minority of patients with intact cognition with largely 
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comparable symptom severity to more cognitively impaired individuals with schizophrenia 
suggests that these illness processes are indeed independent. According to predictions, 
cognitively normal range and below-normal range individuals with schizophrenia had discrepant 
cognitive profiles. Similarities found between the two patient groups may index sensitivity to 
brain aberrations due to psychotic illness. Discrepancies between cognitively normal and below-
normal range patients suggest a possible influence of cognitive impairment. In particular, among 
controls with below-normal range cognitive abilities, there was evidence of poor performance on 
supposed specialized psychopathology-sensitive cognitive measures. In general, the behavioural 
data supported the separable and comorbid contribution of cognition and psychosis to the 
neurocognitive profile.  
 With respect to the neurobiological findings, cognitively normal range controls had 
greater cortical thickness than cognitively normal and below-normal range patients; while the 
patient groups were indistinguishable. Thus, cortical thickness seems to reflect schizophrenia 
illness irrespective of cognitive status, particularly in the salience and default mode networks 
consistent with findings from Heinrichs and colleagues (2017). This finding is also in keeping 
with the neurodevelopmental hypothesis of schizophrenia and evidence of both genetic 
abnormalities and early disruptions in brain development (e.g., arrested cell distribution, 
excessive pruning, diminished myelination) up until early adulthood that predispose individuals 
to the illness (Birmbaum & Weinberger, 2017). However, we did not find evidence to support 
that the social brain network is similarly disrupted across both patient groups. In fact, this brain 
network may underlie comorbid psychopathology and cognitive impairment and thus represent 
dissimilarities between the two patient populations (see below for updated versions of the 
diagrams presented earlier – changes highlighted in blue).  
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 Furthermore, the data revealed that the integrity of particular tracts can independently 
reflect psychotic psychopathology or cognitive status; tract integrity may also be affected by 
comorbid cognitive impairment and psychosis. The genu of the corpus callosum was 
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demyelinated (as indexed by increased radial diffusivity) across patient populations, indicative of 
a common illness effect which further supports the dysconnectivity hypothesis of schizophrenia. 
Of course, similar patterns of white matter integrity may also index similarities in cognitive 
performance as a result of the illness (e.g., reasoning and problem solving), while dissimilarities 
in tract integrity may suggest distinct pathways that give rise to cognitive abnormalities. 
 The more typical patients with cognitive compromise had greater myelin degeneration in 
the superior longitudinal fasciculus when compared to cognitively normal range controls (see 
Figure 1B Revised). The cognitively normal range patients and controls, however, were 
indistinguishable. Here, the imaging results support cognitive impairment and psychosis as 
distinct illness processes. These findings were also consistent with the neurocognitive data in that 
this control group outperformed below-normal range participants on measures of executive 
functions and processing speed, abilities supported by the superior longitudinal fasciculus. 
Nonetheless, while cognitively normal range patients outperformed their cognitively below-
normal range patient counterparts on information processing speed, they were outperformed by 
cognitively normal range controls on both cognitive domains. Our results provide support for the 
increased sensitivity of cognitive performance (relative to neuroimaging) in helping to dissociate 
schizophrenia illness from cognitive impairment. Additional support for the sensitivity of 
cognitive assessment comes from our findings that the cognitively normal range groups had 
different connectivity patterns in the sagittal stratum. This pattern, however, may be indicative of 
cortical efficiency that gives rise to intact cognition in cognitively normal range patients.  
Taken together, the data add further support that cognitive impairment and psychotic 
illness represent dissociable, yet highly comorbid disease processes as indexed by cortical 
thinning and dysconnectivity within and between key networks. Additionally, our results 
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highlight the importance of including both cognitively normal range patients and cognitively 
compromised comparison controls in schizophrenia research. The inclusion of these minority 
participant populations aid in teasing apart the specific contributions of cognitive status and 
psychotic illness. Evidently, studies that utilize longitudinal data, larger sample size, and 
multimodal neuroimaging approaches are needed to corroborate the current findings. These 
studies may further our understanding of schizophrenia as an illness or syndrome to aid in its 
classification and treatment. 
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